KR20160001537A - Pyrazole-based compound and organic light emitting device using the same - Google Patents
Pyrazole-based compound and organic light emitting device using the same Download PDFInfo
- Publication number
- KR20160001537A KR20160001537A KR1020140080245A KR20140080245A KR20160001537A KR 20160001537 A KR20160001537 A KR 20160001537A KR 1020140080245 A KR1020140080245 A KR 1020140080245A KR 20140080245 A KR20140080245 A KR 20140080245A KR 20160001537 A KR20160001537 A KR 20160001537A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- unsubstituted
- substituted
- monocyclic
- polycyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 308
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title abstract description 4
- 239000010410 layer Substances 0.000 claims description 61
- 125000002950 monocyclic group Chemical group 0.000 claims description 55
- 125000001424 substituent group Chemical group 0.000 claims description 28
- 125000003118 aryl group Chemical group 0.000 claims description 19
- -1 klychenylene Chemical group 0.000 claims description 18
- 125000001072 heteroaryl group Chemical group 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 238000002347 injection Methods 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 239000012044 organic layer Substances 0.000 claims description 11
- 125000005551 pyridylene group Chemical group 0.000 claims description 11
- 230000000903 blocking effect Effects 0.000 claims description 9
- 239000011368 organic material Substances 0.000 claims description 9
- 125000003367 polycyclic group Chemical group 0.000 claims description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 125000004653 anthracenylene group Chemical group 0.000 claims description 6
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 claims description 6
- 125000004957 naphthylene group Chemical group 0.000 claims description 6
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 6
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 5
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 230000005525 hole transport Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 229910052805 deuterium Inorganic materials 0.000 claims description 2
- 125000005548 pyrenylene group Chemical group 0.000 claims description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 150000002894 organic compounds Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 description 92
- 238000002360 preparation method Methods 0.000 description 91
- 239000000463 material Substances 0.000 description 57
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000004440 column chromatography Methods 0.000 description 23
- 238000003756 stirring Methods 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 230000032258 transport Effects 0.000 description 11
- 0 *=Cc1cc(Br)ccc1 Chemical compound *=Cc1cc(Br)ccc1 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- MZSAMHOCTRNOIZ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylaniline Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(NC2=CC=CC=C2)C=CC=1 MZSAMHOCTRNOIZ-UHFFFAOYSA-N 0.000 description 8
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 8
- 239000002019 doping agent Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 8
- UFHFLCQGNIYNRP-VVKOMZTBSA-N Dideuterium Chemical compound [2H][2H] UFHFLCQGNIYNRP-VVKOMZTBSA-N 0.000 description 7
- SAHIZENKTPRYSN-UHFFFAOYSA-N [2-[3-(phenoxymethyl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound O(C1=CC=CC=C1)CC=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 SAHIZENKTPRYSN-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 7
- SWGQITQOBPXVRC-UHFFFAOYSA-N methyl 2-bromobenzoate Chemical compound COC(=O)C1=CC=CC=C1Br SWGQITQOBPXVRC-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000010409 thin film Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 125000002947 alkylene group Chemical group 0.000 description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 125000003003 spiro group Chemical group 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 229920000767 polyaniline Polymers 0.000 description 5
- MAGFQRLKWCCTQJ-UHFFFAOYSA-M 4-ethenylbenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C(C=C)C=C1 MAGFQRLKWCCTQJ-UHFFFAOYSA-M 0.000 description 4
- VFUDMQLBKNMONU-UHFFFAOYSA-N 9-[4-(4-carbazol-9-ylphenyl)phenyl]carbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 VFUDMQLBKNMONU-UHFFFAOYSA-N 0.000 description 4
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 4
- UEEXRMUCXBPYOV-UHFFFAOYSA-N iridium;2-phenylpyridine Chemical compound [Ir].C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1 UEEXRMUCXBPYOV-UHFFFAOYSA-N 0.000 description 4
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 3
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 3
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 3
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 235000010290 biphenyl Nutrition 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 3
- 238000005401 electroluminescence Methods 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical compound C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 239000010406 cathode material Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000005560 phenanthrenylene group Chemical group 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000005550 pyrazinylene group Chemical group 0.000 description 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000001771 vacuum deposition Methods 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 1
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- JYAQYXOVOHJRCS-UHFFFAOYSA-N 1-(3-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(Br)=C1 JYAQYXOVOHJRCS-UHFFFAOYSA-N 0.000 description 1
- WYECURVXVYPVAT-UHFFFAOYSA-N 1-(4-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Br)C=C1 WYECURVXVYPVAT-UHFFFAOYSA-N 0.000 description 1
- NVVSJVCWQHRSKT-UHFFFAOYSA-N 1-(4-bromopyridin-2-yl)ethanone Chemical compound CC(=O)C1=CC(Br)=CC=N1 NVVSJVCWQHRSKT-UHFFFAOYSA-N 0.000 description 1
- NXILYROBKJDWFE-UHFFFAOYSA-N 1-(5-bromonaphthalen-2-yl)ethanone Chemical compound BrC1=CC=CC2=CC(C(=O)C)=CC=C21 NXILYROBKJDWFE-UHFFFAOYSA-N 0.000 description 1
- IDZRAUUUHXQGKC-UHFFFAOYSA-N 1-(5-bromopyridin-2-yl)ethanone Chemical compound CC(=O)C1=CC=C(Br)C=N1 IDZRAUUUHXQGKC-UHFFFAOYSA-N 0.000 description 1
- UZDOTHVVSQOCJO-UHFFFAOYSA-N 1-(6-bromonaphthalen-2-yl)ethanone Chemical compound C1=C(Br)C=CC2=CC(C(=O)C)=CC=C21 UZDOTHVVSQOCJO-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- ARMQQOXIHQRINP-UHFFFAOYSA-N 1H-pyrazole quinazoline Chemical class C=1C=NNC=1.N1=CN=CC2=CC=CC=C21 ARMQQOXIHQRINP-UHFFFAOYSA-N 0.000 description 1
- YMMGRPLNZPTZBS-UHFFFAOYSA-N 2,3-dihydrothieno[2,3-b][1,4]dioxine Chemical compound O1CCOC2=C1C=CS2 YMMGRPLNZPTZBS-UHFFFAOYSA-N 0.000 description 1
- VFBJMPNFKOMEEW-UHFFFAOYSA-N 2,3-diphenylbut-2-enedinitrile Chemical group C=1C=CC=CC=1C(C#N)=C(C#N)C1=CC=CC=C1 VFBJMPNFKOMEEW-UHFFFAOYSA-N 0.000 description 1
- NRSBAUDUBWMTGL-UHFFFAOYSA-N 2-(1-benzothiophen-2-yl)pyridine Chemical compound S1C2=CC=CC=C2C=C1C1=CC=CC=N1 NRSBAUDUBWMTGL-UHFFFAOYSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- KAJMDIRNTNSOLE-UHFFFAOYSA-N 2-naphthalen-1-yl-1,3-benzoxazole Chemical compound C1=CC=C2C(C=3OC4=CC=CC=C4N=3)=CC=CC2=C1 KAJMDIRNTNSOLE-UHFFFAOYSA-N 0.000 description 1
- XBHOUXSGHYZCNH-UHFFFAOYSA-N 2-phenyl-1,3-benzothiazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2S1 XBHOUXSGHYZCNH-UHFFFAOYSA-N 0.000 description 1
- FIISKTXZUZBTRC-UHFFFAOYSA-N 2-phenyl-1,3-benzoxazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2O1 FIISKTXZUZBTRC-UHFFFAOYSA-N 0.000 description 1
- QLPKTAFPRRIFQX-UHFFFAOYSA-N 2-thiophen-2-ylpyridine Chemical compound C1=CSC(C=2N=CC=CC=2)=C1 QLPKTAFPRRIFQX-UHFFFAOYSA-N 0.000 description 1
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 1
- SUISZCALMBHJQX-UHFFFAOYSA-N 3-bromobenzaldehyde Chemical compound BrC1=CC=CC(C=O)=C1 SUISZCALMBHJQX-UHFFFAOYSA-N 0.000 description 1
- VJHVLELNDFVKMS-UHFFFAOYSA-N 3-methoxy-2-phenylpyridine Chemical compound COC1=CC=CN=C1C1=CC=CC=C1 VJHVLELNDFVKMS-UHFFFAOYSA-N 0.000 description 1
- DDTHMESPCBONDT-UHFFFAOYSA-N 4-(4-oxocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-one Chemical class C1=CC(=O)C=CC1=C1C=CC(=O)C=C1 DDTHMESPCBONDT-UHFFFAOYSA-N 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- CKVQWOKUEZYWRQ-UHFFFAOYSA-N 4-bromopyridine-2-carbaldehyde Chemical compound BrC1=CC=NC(C=O)=C1 CKVQWOKUEZYWRQ-UHFFFAOYSA-N 0.000 description 1
- DIVZFUBWFAOMCW-UHFFFAOYSA-N 4-n-(3-methylphenyl)-1-n,1-n-bis[4-(n-(3-methylphenyl)anilino)phenyl]-4-n-phenylbenzene-1,4-diamine Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)N(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 DIVZFUBWFAOMCW-UHFFFAOYSA-N 0.000 description 1
- OQAFFLFJQFWYHB-UHFFFAOYSA-N 5-bromonaphthalene-2-carbaldehyde Chemical compound O=CC1=CC=C2C(Br)=CC=CC2=C1 OQAFFLFJQFWYHB-UHFFFAOYSA-N 0.000 description 1
- ZQVLPMNLLKGGIU-UHFFFAOYSA-N 5-bromopyridine-2-carbaldehyde Chemical compound BrC1=CC=C(C=O)N=C1 ZQVLPMNLLKGGIU-UHFFFAOYSA-N 0.000 description 1
- DLLDUYJRQNTEOR-UHFFFAOYSA-N 6-bromonaphthalene-2-carbaldehyde Chemical compound C1=C(C=O)C=CC2=CC(Br)=CC=C21 DLLDUYJRQNTEOR-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- UHBIKXOBLZWFKM-UHFFFAOYSA-N 8-hydroxy-2-quinolinecarboxylic acid Chemical compound C1=CC=C(O)C2=NC(C(=O)O)=CC=C21 UHBIKXOBLZWFKM-UHFFFAOYSA-N 0.000 description 1
- DWTHABKUXUAATM-UHFFFAOYSA-N Brc(cccc1)c1-c1cc(-c2ccccc2)n[nH]1 Chemical compound Brc(cccc1)c1-c1cc(-c2ccccc2)n[nH]1 DWTHABKUXUAATM-UHFFFAOYSA-N 0.000 description 1
- IHBRWVSCMFDZOW-UHFFFAOYSA-N Brc1cc(-c2nc3ccccc3c3cc(-c4ccccc4)n[n]23)ccc1 Chemical compound Brc1cc(-c2nc3ccccc3c3cc(-c4ccccc4)n[n]23)ccc1 IHBRWVSCMFDZOW-UHFFFAOYSA-N 0.000 description 1
- OXNBEWYKCXBCOG-UHFFFAOYSA-N Brc1cc(C(Nc(cccc2)c2-c2c3)[n]2nc3-c2ccccc2)ccc1 Chemical compound Brc1cc(C(Nc(cccc2)c2-c2c3)[n]2nc3-c2ccccc2)ccc1 OXNBEWYKCXBCOG-UHFFFAOYSA-N 0.000 description 1
- WTILAHLQQHYMRZ-UHFFFAOYSA-N C(C1)C=CC=C1c1n[n]2c(-c3cccc([AlH]c4cccc(-c5nc(cccc6)c6c6cc(-c7ccccc7)n[n]56)c4)c3)nc(cccc3)c3c2c1 Chemical compound C(C1)C=CC=C1c1n[n]2c(-c3cccc([AlH]c4cccc(-c5nc(cccc6)c6c6cc(-c7ccccc7)n[n]56)c4)c3)nc(cccc3)c3c2c1 WTILAHLQQHYMRZ-UHFFFAOYSA-N 0.000 description 1
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N CCC(c1ccccc1)=O Chemical compound CCC(c1ccccc1)=O KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 1
- JDPWSWFJXYITOW-UHFFFAOYSA-N CCOCc1cc2cccc(C)c2cc1 Chemical compound CCOCc1cc2cccc(C)c2cc1 JDPWSWFJXYITOW-UHFFFAOYSA-N 0.000 description 1
- WVWZECQNFWFVFW-UHFFFAOYSA-N Cc(cccc1)c1C(OC)=O Chemical compound Cc(cccc1)c1C(OC)=O WVWZECQNFWFVFW-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- GNOYRJIXSUNXIH-UHFFFAOYSA-N N1=CNC2=C3C=NN=C3C=CC2=C1 Chemical compound N1=CNC2=C3C=NN=C3C=CC2=C1 GNOYRJIXSUNXIH-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- FOYARDQRQXBRJQ-UHFFFAOYSA-N O=C(CC(c1ccccc1Br)=O)c1ccccc1 Chemical compound O=C(CC(c1ccccc1Br)=O)c1ccccc1 FOYARDQRQXBRJQ-UHFFFAOYSA-N 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- 125000004054 acenaphthylenyl group Chemical group C1(=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000005566 carbazolylene group Chemical group 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000000597 dioxinyl group Chemical group 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 description 1
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical group C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- DCZNSJVFOQPSRV-UHFFFAOYSA-N n,n-diphenyl-4-[4-(n-phenylanilino)phenyl]aniline Chemical class C1=CC=CC=C1N(C=1C=CC(=CC=1)C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 DCZNSJVFOQPSRV-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 125000003933 pentacenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C12)* 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 150000003219 pyrazolines Chemical class 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 1
- 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000005558 triazinylene group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/15—Hole transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
- H10K50/171—Electron injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
본 출원은 피라졸계 화합물 및 이를 포함하는 유기발광소자에 관한 것이다. The present invention relates to a pyrazole-based compound and an organic light emitting device comprising the same.
Description
본 출원은 신규한 피라졸계 화합물 및 이를 포함하는 유기발광소자에 관한 것이다.The present invention relates to a novel pyrazole-based compound and an organic light-emitting device comprising the same.
전계 발광 소자는 자체 발광형 표시 소자의 일종으로서, 시야각이 넓고, 콘트라스트가 우수할 뿐만 아니라 응답속도가 빠르다는 장점을 가지고 있다. An electroluminescent device is one type of self-luminous display device, and has advantages of wide viewing angle, excellent contrast, and high response speed.
유기발광소자는 2개의 전극 사이에 유기박막을 배치시킨 구조를 가지고 있다. 이와 같은 구조의 유기발광소자에 전압이 인가되면, 2개의 전극으로부터 주입된 전자와 정공이 유기박막에서 결합하여 쌍을 이룬 후 소멸하면서 빛을 발하게 된다. 상기 유기박막은 필요에 따라 단층 또는 다층으로 구성될 수 있다. The organic light emitting device has a structure in which an organic thin film is disposed between two electrodes. When a voltage is applied to the organic light emitting device having such a structure, electrons and holes injected from the two electrodes couple to each other in the organic thin film and form a pair, which then extinguishes and emits light. The organic thin film may be composed of a single layer or a multilayer, if necessary.
유기박막의 재료는 필요에 따라 발광 기능을 가질 수 있다. 예컨대, 유기박막 재료로는 그 자체가 단독으로 발광층을 구성할 수 있는 화합물이 사용될 수도 있고, 또는 호스트-도펀트계 발광층의 호스트 또는 도펀트 역할을 할 수 있는 화합물이 사용될 수도 있다. 그 외에도, 유기박막의 재료로서, 정공주입, 정공수송, 전자저지, 정공저지, 전자수송 또는 전자주입 등의 역할을 수행할 수 있는 화합물이 사용될 수도 있다.The material of the organic thin film may have a light emitting function as needed. For example, as the organic thin film material, a compound capable of forming a light emitting layer by itself may be used, or a compound capable of serving as a host or a dopant of a host-dopant light emitting layer may be used. In addition, as the material of the organic thin film, a compound capable of performing a role such as hole injection, hole transport, electron blocking, hole blocking, electron transport or electron injection may be used.
유기발광소자의 성능, 수명 또는 효율을 향상시키기 위하여, 유기박막의 재료의 개발이 지속적으로 요구되고 있다.In order to improve the performance, life or efficiency of an organic light emitting device, development of materials for organic thin films is continuously required.
본 출원은 신규한 피라졸계 화합물 및 이를 포함하는 유기발광소자를 제공한다.The present invention provides a novel pyrazole-based compound and an organic light-emitting device comprising the same.
본 출원은 하기 화학식 1의 화합물을 제공한다.The present application provides compounds of formula (1).
[화학식 1][Chemical Formula 1]
상기 화학식 1에 있어서, In Formula 1,
L1 내지 L3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴렌; 또는 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴렌이고,L1 to L3 are the same or different and each independently represents a substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic arylene; Or a substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroarylene,
t는 0 내지 5의 정수이며,t is an integer from 0 to 5,
R1 내지 R4는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐; 치환 또는 비치환된 C1 내지 C60의 직쇄 또는 분지쇄의 알킬; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알케닐; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알키닐; 치환 또는 비치환된 C3 내지 C60의 단환 또는 다환의 시클로알킬; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로시클로알킬; 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴; -SiRR'R"; -P(=O)RR'; 및 -NRR'으로 이루어진 군으로부터 선택되며,R1 to R4 are the same or different from each other, and each independently hydrogen; heavy hydrogen; halogen; Substituted or unsubstituted C 1 to C 60 straight or branched alkyl; Substituted or unsubstituted C 2 to C 60 straight or branched chain alkenyl; Substituted or unsubstituted C 2 to C 60 straight or branched chain alkynyl; A substituted or unsubstituted C 3 to C 60 monocyclic or polycyclic cycloalkyl; Substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heterocycloalkyl; A substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl; Substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroaryl; -SiRR'R "; -P (= O) RR '; and -NRR'
상기 R, R 및 R"은 서로 동일하거나 상이하고, 각각 독립적으로 수소; C1 내지 C60의 직쇄 또는 분지쇄의 알킬; 치환 또는 비치환된 C3 내지 C60의 단환 또는 다환의 시클로알킬; C6 내지 C60의 단환 또는 다환의 아릴; 및 C2 내지 C60의 단환 또는 다환의 헤테로아릴로 이루어진 군으로부터 선택되며,Wherein R, R and R "are the same or different from each other and each independently represents hydrogen; C 1 to C 60 linear or branched alkyl; substituted or unsubstituted C 3 to C 60 monocyclic or polycyclic cycloalkyl; A C 6 to C 60 monocyclic or polycyclic aryl, and a C 2 to C 60 monocyclic or polycyclic heteroaryl,
m 및 n은 각각 독립적으로 0 내지 4의 정수이고,m and n are each independently an integer of 0 to 4,
p 및 q는 각각 독립적으로 0 내지 2의 정수이며,p and q are each independently an integer of 0 to 2,
상기 m, n, p, q 및 t가 각각 2 이상의 정수일 때, 각각의 괄호 안에 있는 치환기는 서로 동일하거나 상이하다.When m, n, p, q, and t are each an integer of 2 or more, the substituents in each parenthesis are the same or different from each other.
또한, 본 출원은 양극, 음극 및 상기 양극과 음극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기발광소자로서, 상기 유기물층 중 1층 이상이 상기 화학식 1의 화합물을 포함하는 유기발광소자를 제공한다.In addition, the present application provides an organic light emitting device including a cathode, a cathode, and at least one organic layer provided between the anode and the cathode, wherein at least one of the organic layers includes the compound of Formula 1 .
본 명세서에 기재된 화합물은 유기발광소자의 유기물층 재료로서 사용할 수 있다. 상기 화합물은 유기발광소자에서 정공주입재료, 정공수송재료, 발광재료, 전자수송재료, 전자주입재료 등의 역할을 할 수 있다. The compound described in this specification can be used as an organic layer material of an organic light emitting device. The compound can act as a hole injecting material, a hole transporting material, a light emitting material, an electron transporting material, an electron injecting material, and the like in an organic light emitting device.
특히, 상기 화학식 1의 화합물은 유기발광소자의 전자수송층의 재료로서 사용될 수 있다. In particular, the compound of Formula 1 may be used as a material of an electron transport layer of an organic light emitting device.
또한, 상기 화학식 1의 화합물은 유기발광소자의 정공저지층의 재료로서 사용될 수 있다. The compound of Formula 1 may be used as a hole blocking layer of an organic light emitting device.
또한, 상기 화학식 1의 화합물은 유기발광소자의 발광층의 재료로 사용될 수 있다.The compound of Formula 1 may be used as a material of the light emitting layer of the organic light emitting device.
도 1 내지 3은 본 출원의 실시상태들에 따른 유기발광소자의 전극과 유기물층의 적층순서를 예시한 것이다.FIGS. 1 to 3 illustrate the stacking order of electrodes and organic layers of the organic light emitting diode according to the embodiments of the present application.
이하, 본 출원에 대하여 상세히 설명한다.Hereinafter, the present application will be described in detail.
본 명세서에 기재된 화합물은 상기 화학식 1로 표시될 수 있다. 구체적으로, 상기 화학식 1의 화합물은 상기와 같은 코어 구조 및 치환기의 구조적 특징에 의하여 유기발광소자의 유기물층 재료로 사용될 수 있다.The compounds described in this specification can be represented by the above formula (1). Specifically, the compound of Formula 1 may be used as an organic material layer material of an organic light emitting diode according to the structural features of the core structure and the substituent.
특히, 상기 화학식 1의 화합물은 강한 전자 끌어당김 특성(Electron Withdrawing effect)을 가지고 있는 피라졸로퀴나졸린의 다이머 구조로서, 전자수송층의 재료로 사용되는 경우 발광층으로 전자 전달이 용이하고, 선형 구조를 가지고 있어 분자간 패킹(packing)이 용이하여 우수한 전자 이동도의 효과를 나타낼 수 있다.In particular, the compound of Chemical Formula 1 is a dimer structure of pyrazoloquinazoline having a strong electron attracting property. When the compound is used as a material of an electron transport layer, it is easy to transfer electrons to a light emitting layer and has a linear structure And thus it is possible to facilitate the intermolecular packing and to exhibit the effect of excellent electron mobility.
뿐만 아니라, 상기 화학식 1의 화합물은 2개의 피라졸로퀴나졸린들 사이에 위치한 연결기로서 다양한 아릴 또는 헤테로 아릴을 포함하도록 구조를 설계할 수 있고, 합성 및 정제가 용이하다.In addition, the compound of Formula 1 can be designed to include various aryls or heteroaryls as a linking group located between two pyrazole quinazolines, and it is easy to synthesize and purify.
본 명세서에 있어서, "치환 또는 비치환"이란 할로겐; C1 내지 C60의 직쇄 또는 분지쇄의 알킬; C2 내지 C60의 직쇄 또는 분지쇄의 알케닐; C2 내지 C60의 직쇄 또는 분지쇄의 알키닐; C3 내지 C60의 단환 또는 다환의 시클로알킬; C2 내지 C60의 단환 또는 다환의 헤테로시클로알킬; C6 내지 C60의 단환 또는 다환의 아릴; C2 내지 C60의 단환 또는 다환의 헤테로아릴; -SiRR'R"; -P(=O)RR'; 및 -NRR'으로 이루어진 군으로부터 선택된 1 이상의 치환기로 치환 또는 비치환되거나, 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환기로 치환 또는 비치환된 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 비페닐기일 수 있다. 즉, 비페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 있다. 상기 R, R' 및 R"은 서로 동일하거나 상이하고, 각각 독립적으로 C1 내지 C60의 직쇄 또는 분지쇄의 알킬; C6 내지 C60의 단환 또는 다환의 아릴; 또는 C2 내지 C60의 단환 또는 다환의 헤테로아릴이다.In the present specification, the term "substituted or unsubstituted" means halogen; C 1 to C 60 linear or branched alkyl; C 2 to C 60 straight or branched chain alkenyl; C 2 to C 60 linear or branched alkynyl; C 3 to C 60 monocyclic or polycyclic cycloalkyl; A C 2 to C 60 monocyclic or polycyclic heterocycloalkyl; C 6 to C 60 monocyclic or polycyclic aryl; C 2 to C 60 monocyclic or polycyclic heteroaryl; -SiRR'R ", -P (= O) RR ', and -NRR', or a substituted or unsubstituted aryl group, wherein at least two of the substituents exemplified above are substituted, For example, the "substituent group to which two or more substituents are connected" may be a biphenyl group, that is, the biphenyl group may be an aryl group, and two phenyl groups may be connected to each other. R "are the same or different and are each independently selected from the group consisting of C 1 to C 60 linear or branched alkyl; C 6 to C 60 monocyclic or polycyclic aryl; Or a C 2 to C 60 monocyclic or polycyclic heteroaryl.
본 명세서에 있어서, 할로겐은 F, Cl, Br 및 I를 포함한다.In the present specification, the halogen includes F, Cl, Br and I.
본 명세서에 있어서, 알킬은 탄소수 1 내지 60의 직쇄 또는 분지쇄를 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 알킬의 탄소수는 1 내지 60, 구체적으로 1 내지 40, 더욱 구체적으로, 1 내지 20일 수 있다. In the present specification, alkyl includes straight or branched chain having 1 to 60 carbon atoms, and may be further substituted by other substituents. The carbon number of the alkyl may be 1 to 60, specifically 1 to 40, more specifically 1 to 20.
본 명세서에 있어서, 알케닐은 탄소수 2 내지 60의 직쇄 또는 분지쇄를 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 알케닐의 탄소수는 2 내지 60, 구체적으로 2 내지 40, 더욱 구체적으로, 2 내지 20일 수 있다. In the present specification, alkenyl includes straight or branched chain having 2 to 60 carbon atoms, and may be further substituted by other substituents. The carbon number of the alkenyl may be 2 to 60, specifically 2 to 40, more specifically, 2 to 20.
본 명세서에 있어서, 알키닐은 탄소수 2 내지 60의 직쇄 또는 분지쇄를 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 알키닐의 탄소수는 2 내지 60, 구체적으로 2 내지 40, 더욱 구체적으로, 2 내지 20일 수 있다. In the present specification, alkynyl includes a straight chain or a branched chain having 2 to 60 carbon atoms, and may be further substituted by other substituents. The carbon number of the alkynyl may be 2 to 60, specifically 2 to 40, more specifically, 2 to 20.
본 명세서에 있어서, 시클로알킬은 탄소수 3 내지 60의 단환 또는 다환을 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 여기서, 다환이란 시클로알킬이 다른 고리기와 직접 연결되거나 축합된 기를 의미한다. 여기서, 다른 고리기란 시클로알킬일 수도 있으나, 다른 종류의 고리기, 예컨대 헤테로시클로알킬, 아릴, 헤테로아릴 등일 수도 있다. 시클로알킬의 탄소수는 3 내지 60, 구체적으로 3 내지 40, 더욱 구체적으로 5 내지 20일 수 있다. In the present specification, the cycloalkyl includes monocyclic or polycyclic rings having 3 to 60 carbon atoms, and may be further substituted by other substituents. Here, the polycyclic ring means a group in which cycloalkyl is directly connected to another ring group or condensed. Here, the other ring group may be a cycloalkyl group, but may be other ring groups such as heterocycloalkyl, aryl, heteroaryl, and the like. The carbon number of the cycloalkyl may be 3 to 60, specifically 3 to 40, more particularly 5 to 20.
본 명세서에 있어서, 헤테로시클로알킬은 헤테로원자로서 O, S, Se, N 또는 Si를 포함하고, 탄소수 2 내지 60의 단환 또는 다환을 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 여기서, 다환이란 헤테로시클로알킬이 다른 고리기와 직접 연결되거나 축합된 기를 의미한다. 여기서, 다른 고리기란 헤테로시클로알킬일 수도 있으나, 다른 종류의 고리기, 예컨대 시클로알킬, 아릴, 헤테로아릴 등일 수도 있다. 헤테로시클로알킬의 탄소수는 2 내지 60, 구체적으로 2 내지 40, 더욱 구체적으로 3 내지 20일 수 있다. In the present specification, heterocycloalkyl includes O, S, Se, N or Si as a heteroatom and includes monocyclic or polycyclic rings having 2 to 60 carbon atoms, and may be further substituted by other substituents. Here, the polycyclic ring means a group in which heterocycloalkyl is directly connected to another ring group or condensed. Here, the other ring group may be heterocycloalkyl, but may be other ring groups such as cycloalkyl, aryl, heteroaryl, and the like. The heterocycloalkyl may have from 2 to 60 carbon atoms, specifically from 2 to 40, more specifically from 3 to 20 carbon atoms.
본 명세서에 있어서, 아릴은 탄소수 6 내지 60의 단환 또는 다환을 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 여기서, 다환이란 아릴이 다른 고리기와 직접 연결되거나 축합된 기를 의미한다. 여기서, 다른 고리기란 아릴일 수도 있으나, 다른 종류의 고리기, 예컨대 시클로알킬, 헤테로시클로알킬, 헤테로아릴 등일 수도 있다. 아릴은 스피로기를 포함한다. 아릴의 탄소수는 6 내지 60, 구체적으로 6 내지 40, 더욱 구체적으로 6 내지 25일 수 있다. 아릴의 구체적인 예로는 페닐, 비페닐, 트리페닐, 나프틸, 안트라세닐, 크라이세닐, 페난트레닐, 페릴레닐, 플루오란테닐, 트리페닐레닐, 페날레닐, 파이레닐, 테트라세닐, 펜타세닐, 플루오레닐, 인데닐, 아세나프틸레닐, 플루오레닐, 벤조플루오레닐, 스피로비플루오레닐, 스피로사이클로펜테인플루오레닐 등이나 이들의 축합고리가 있으나, 이에만 한정되는 것은 아니다.In the present specification, aryl includes monocyclic or polycyclic rings having 6 to 60 carbon atoms and may be further substituted by other substituents. Here, the polycyclic ring means a group in which aryl is directly connected to another ring group or condensed. Here, the other ring group may be aryl, but may be other ring groups such as cycloalkyl, heterocycloalkyl, heteroaryl and the like. Aryl includes a spiro group. The carbon number of the aryl may be 6 to 60, specifically 6 to 40, more specifically 6 to 25. Specific examples of aryl include phenyl, biphenyl, triphenyl, naphthyl, anthracenyl, klycenyl, phenanthrenyl, perylenyl, fluoranthenyl, triphenylenyl, phenalenyl, pyrenyl, tetracenyl, pentacenyl, But are not limited to, fluorenyl, indenyl, acenaphthylenyl, fluorenyl, benzofluorenyl, spirobifluorenyl, spirocyclopentafluorenyl, and condensed rings thereof.
본 명세서에 있어서, 스피로기는 스피로 구조를 포함하는 기로서, 탄소수 15 내지 60일 수 있다. 예컨대, 스피로기는 플루오렌기에 2,3-디하이드로-1H-인덴기 또는 시클로헥산기가 스피로 결합된 구조를 포함할 수 있다. 구체적으로, 스피로기는 하기 구조식의 기를 포함한다.In the present specification, the spiro group is a group including a spiro structure and may have from 15 to 60 carbon atoms. For example, a spiro group may include a structure in which a 2,3-dihydro-1H-indene group or a cyclohexane group is spiro-bonded to a fluorene group. Specifically, the spiro group includes groups of the following structural formulas.
본 명세서에 있어서, 헤테로아릴은 헤테로원자로서 S, O, Se, N 또는 Si를 포함하고, 탄소수 2 내지 60인 단환 또는 다환을 포함하며, 다른 치환기에 의하여 추가로 치환될 수 있다. 여기서, 다환이란 헤테로아릴이 다른 고리기와 직접 연결되거나 축합된 기를 의미한다. 여기서, 다른 고리기란 헤테로아릴일 수도 있으나, 다른 종류의 고리기, 예컨대 시클로알킬, 헤테로시클로알킬, 아릴 등일 수도 있다. 헤테로아릴의 탄소수는 2 내지 60, 구체적으로 2 내지 40, 더욱 구체적으로 3 내지 25일 수 있다. 헤테로아릴의 구체적인 예로는 피리딜, 피롤릴, 피리미딜, 피리다지닐, 푸라닐, 티오페닐, 이미다졸릴, 피라졸릴, 옥사졸릴, 이속사졸릴, 티아졸릴, 이소티아졸릴, 트리아졸릴, 푸라자닐, 옥사디아졸릴, 티아디아졸릴, 디티아졸릴, 테트라졸릴, 파이라닐, 티오파이라닐, 디아지닐, 옥사지닐, 옥사디아졸릴, 티아지닐, 디옥시닐, 트리아지닐, 테트라지닐, 시놀리닐, 퀴놀릴, 이소퀴놀릴, 퀴녹살리닐, 퀴나졸리닐, 이소퀴나졸리닐, 나프티리딜, 아크리디닐, 페난트리디닐, 이미다조피리디닐, 디아자나프탈레닐, 트리아자인덴, 인돌릴, 인돌리지닐, 벤조티아졸릴, 벤즈옥사졸릴, 벤즈이미다졸릴, 벤조티오페닐, 벤조푸라닐, 디벤조티오페닐, 디벤조푸라닐, 카바졸릴, 벤조카바졸릴, 디벤조카바졸릴, 페나지닐, 디벤조실롤릴, 디벤조셀레노페닐, 디벤조실리닐, 크산테닐, 싸이오크산테닐, 셀레녹산테닐, 디히드로페나지닐, 페녹사지닐, 페난트리딜, 피라졸로프탈라지닐, 피라졸로퀴나졸릴, 피리도인다졸릴 등이나 이들의 축합고리가 있으나, 이에만 한정되는 것은 아니다.As used herein, heteroaryl includes S, O, Se, N or Si as a heteroatom and includes monocyclic or polycyclic rings having 2 to 60 carbon atoms and may be further substituted by other substituents. Herein, the term "polycyclic" means a heteroaryl group directly bonded to another ring group or condensed therewith. Here, the other ring group may be heteroaryl, but may be other ring groups such as cycloalkyl, heterocycloalkyl, aryl, and the like. The heteroaryl may have 2 to 60 carbon atoms, specifically 2 to 40, more specifically 3 to 25 carbon atoms. Specific examples of heteroaryl include pyridyl, pyrrolyl, pyrimidyl, pyridazinyl, furanyl, thiophenyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, Thiadiazolyl, thiazolyl, thiazolyl, pyrazinyl, thiopyranyl, diazinyl, oxazinyl, oxadiazolyl, thiazinyl, dioxinyl, triazinyl, tetrazinyl, Thiazolidinyl, quinolyl, isoquinolyl, quinazolinyl, quinazolinyl, isoquinazolinyl, naphthyridyl, acridinyl, phenanthridinyl, imidazopyridinyl, diazanaphthalenyl, triazinene, Benzothiophenyl, benzothiophenyl, dibenzofuranyl, carbazolyl, benzocarbazolyl, dibenzocarbazolyl, benzothiazolyl, benzothiazolyl, benzothiazolyl, benzothiophenyl, benzofuranyl, Phenazinyl, dibenzosiloryl, dibenzoselenophenyl, dibenzosilinyl, There may be mentioned condensed rings such as thienyl, thienyl, thioxanthienyl, selenoxanthienyl, dihydrophenazinyl, phenoxazinyl, phenanthridyl, pyrazolaphthalazinyl, pyrazoloquinazolyl and pyridoindazolyl. But is not limited thereto.
본 명세서에 있어서, 상기 m, n, p, q 및 t는 각각 R1, R2, R3, R4 및 L2의 개수를 의미한다.In the present specification, m, n, p, q and t mean the numbers of R1, R2, R3, R4 and L2, respectively.
본 출원의 일 실시상태에 따르면, 상기 m이 2 이상의 정수일 때, R1은 서로 동일하거나 상이할 수 있다.According to one embodiment of the present application, when m is an integer of 2 or more, R1 may be the same as or different from each other.
본 출원의 일 실시상태에 따르면, 상기 n이 2 이상의 정수일 때, R2는 서로 동일하거나 상이할 수 있다.According to an embodiment of the present application, when n is an integer of 2 or more, R2 may be the same or different from each other.
본 출원의 일 실시상태에 따르면, 상기 p가 2 이상의 정수일 때, R3는 서로 동일하거나 상이할 수 있다.According to one embodiment of the present application, when p is an integer of 2 or more, R3 may be the same as or different from each other.
본 출원의 일 실시상태에 따르면, 상기 q가 2 이상의 정수일 때, R4는 서로 동일하거나 상이할 수 있다.According to one embodiment of the present application, when q is an integer of 2 or more, R4 may be the same as or different from each other.
본 출원의 일 실시상태에 따르면, 상기 t가 2 이상의 정수일 때, L2는 서로 동일하거나 상이할 수 있다.According to one embodiment of the present application, when t is an integer of 2 or more, L2 may be the same or different from each other.
본 출원의 일 실시상태에 따르면, 상기 L1 내지 L3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6 내지 C20의 단환 또는 다환의 아릴렌; 또는 치환 또는 비치환된 C2 내지 C20의 단환 또는 다환의 헤테로아릴렌이다.According to one embodiment of the present application, L1 to L3 are the same or different and each independently represents a substituted or unsubstituted C 6 to C 20 monocyclic or polycyclic arylene; Or a substituted or unsubstituted C 2 to C 20 monocyclic or polycyclic heteroarylene.
본 출원의 일 실시상태에 따르면, 상기 L1 및 L3는 서로 동일하거나 상이하고, 각각 독립적으로 페닐렌, 비페닐렌, 나프틸렌, 안트라세닐렌, 피리딜렌, 피리미딜렌 및 트리아지닐렌으로 이루어진 군으로부터 선택되고, According to one embodiment of the present application, L1 and L3 are the same or different from each other and each independently represent a group consisting of phenylene, biphenylene, naphthylene, anthracenylene, pyridylene, pyrimidylene, and triazienylene ≪ / RTI >
C1~C20의 알킬, C6~C20의 아릴, 또는 C2~C20의 헤테로아릴로 더 치환되거나 비치환될 수 있다.Which may be further substituted or unsubstituted with C 1 -C 20 alkyl, C 6 -C 20 aryl, or C 2 -C 20 heteroaryl.
즉, 상기 L1 및 L3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 페닐렌, 치환 또는 비치환된 비페닐렌, 치환 또는 비치환된 나프틸렌, 치환 또는 비치환된 안트라세닐렌, 치환 또는 비치환된 피리딜렌, 치환 또는 비치환된 피리미딜렌, 및 치환 또는 비치환된 트리아지닐렌으로 이루어진 군으로부터 선택되고, That is, L1 and L3 are the same or different and each independently represents a substituted or unsubstituted phenylene, substituted or unsubstituted biphenylene, substituted or unsubstituted naphthylene, substituted or unsubstituted anthracenylene, Substituted or unsubstituted pyridylenes, substituted or unsubstituted pyridylenes, substituted or unsubstituted pyrimidylenes, and substituted or unsubstituted triazinylenes,
상기 "치환 또는 비치환된"은 C1~C20의 알킬, C6~C20의 아릴, 및 C2~C20의 헤테로아릴 중에서 선택되는 적어도 하나로 더 치환되거나 비치환될 수 있음을 의미한다.Means that the "substituted or unsubstituted" may be further substituted or unsubstituted with at least one selected from C 1 -C 20 alkyl, C 6 -C 20 aryl, and C 2 -C 20 heteroaryl .
본 출원의 일 실시상태에 따르면, 상기 L2는 페닐렌, 비페닐렌, 나프틸렌, 안트라세닐렌, 페난트레닐렌, 크라이세닐렌, 파이레닐렌, 트리페닐레닐렌, 피리딜렌, 피리미딜렌, 트리아지닐렌, 플루오렌, 스피로사이클로펜테인플루오레닐렌, 카바졸릴렌, 디벤조티오페닐렌, 디벤조푸라닐렌, 디벤조셀레노페닐렌, 디벤조실롤릴렌, 아크리디닐렌, 크산테닐렌, 싸이오크산테닐렌, 디벤조실리닐렌 및 셀레녹산테닐렌으로 이루어진 군으로부터 선택되고, According to one embodiment of the present application, L2 is selected from the group consisting of phenylene, biphenylene, naphthylene, anthracenylene, phenanthrenylene, chrysinylene, pyrenylene, triphenylrenylene, pyridylene, Wherein the aromatic ring is selected from the group consisting of a substituted or unsubstituted alkylene, a substituted or unsubstituted alkylene, a substituted or unsubstituted alkylene, a substituted or unsubstituted alkylene, a substituted or unsubstituted alkylene, a substituted or unsubstituted alkylene, Thioxanthrenylene, dibenzosiliconylene, and selenoxanthienylene, and the sum of
C1~C20의 알킬, C6~C20의 아릴, 또는 C2~C20의 헤테로아릴로 더 치환되거나 비치환될 수 있다.Which may be further substituted or unsubstituted with C 1 -C 20 alkyl, C 6 -C 20 aryl, or C 2 -C 20 heteroaryl.
즉, 상기 L2는 치환 또는 비치환된 페닐렌, 치환 또는 비치환된 비페닐렌, 나프틸렌, 치환 또는 비치환된 안트라세닐렌, 치환 또는 비치환된 페난트레닐렌, 치환 또는 비치환된 크라이세닐렌, 치환 또는 비치환된 파이레닐렌, 치환 또는 비치환된 트리페닐레닐렌, 치환 또는 비치환된 피리딜렌, 치환 또는 비치환된 피리미딜렌, 치환 또는 비치환된 트리아지닐렌, 치환 또는 비치환된 플루오렌, 치환 또는 비치환된 스피로사이클로펜테인플루오레닐렌, 치환 또는 비치환된 카바졸릴렌, 치환 또는 비치환된 디벤조티오페닐렌, 치환 또는 비치환된 디벤조푸라닐렌, 치환 또는 비치환된 디벤조셀레노페닐렌, 치환 또는 비치환된 디벤조실롤릴렌, 치환 또는 비치환된 아크리디닐렌, 치환 또는 비치환된 크산테닐렌, 치환 또는 비치환된 싸이오크산테닐렌, 치환 또는 비치환된 디벤조실리닐렌, 및 치환 또는 비치환된 셀레녹산테닐렌으로 이루어진 군으로부터 선택되고,That is, the L2 may be substituted or unsubstituted phenylene, substituted or unsubstituted biphenylene, naphthylene, substituted or unsubstituted anthracenylene, substituted or unsubstituted phenanthrenylene, substituted or unsubstituted crecenyl Substituted or unsubstituted pyridylenes, substituted or unsubstituted pyridylenes, substituted or unsubstituted pyridylenes, substituted or unsubstituted pyridylenes, substituted or unsubstituted pyrazinylenes, substituted or unsubstituted pyrazinylenes, substituted or unsubstituted pyridylenes, Substituted or unsubstituted dibenzothiophenylene, substituted or unsubstituted dibenzofuranylene, substituted or unsubstituted spirocyclopentafluorenylenylene, substituted or unsubstituted carbazolylene, substituted or unsubstituted dibenzothiophenylene, substituted or unsubstituted dibenzofuranylene, Unsubstituted dibenzoselenophenylene, substituted or unsubstituted dibenzosilolylene, substituted or unsubstituted acrylidynylene, substituted or unsubstituted xanthenylene, substituted or unsubstituted thioxanthrenylene, substituted Or unsubstituted dibenzosilinylene, and substituted or unsubstituted stenylene selenate,
상기 "치환 또는 비치환된"은 C1~C20의 알킬, C6~C20의 아릴, 및 C2~C20의 헤테로아릴 중에서 선택되는 적어도 하나로 더 치환되거나 비치환될 수 있음을 의미한다.Means that the "substituted or unsubstituted" may be further substituted or unsubstituted with at least one selected from C 1 -C 20 alkyl, C 6 -C 20 aryl, and C 2 -C 20 heteroaryl .
본 출원의 일 실시상태에 따르면, 상기 L2는 메틸, 에틸, 프로필, 부틸, 페닐, 비페닐, 나프틸, 안트라세닐, 페난트레닐, 크라이세닐, 파이레닐, 트리페닐레닐, 플루오레닐, 피리딜, 피리미딜, 트리아지닐, 카바졸릴, 디벤조푸라닐, 디벤조티오페닐, 디벤조실롤릴, 디벤조셀레노페닐, 아크리디닐, 크산테닐, 싸이오크산테닐, 디벤조실리닐, 또는 셀레녹산테닐로 더 치환될 수 있다. 또한, 상기 플루오레닐은 전술한 스피로기를 포함할 수 있다.According to one embodiment of the present application, L2 is selected from the group consisting of methyl, ethyl, propyl, butyl, phenyl, biphenyl, naphthyl, anthracenyl, phenanthrenyl, Dibenzothiophenyl, dibenzosilylolyl, dibenzoselenophenyl, acridinyl, xanthenyl, thioxanthinyl, dibenzosilinyl, dibenzothiophenyl, dibenzothiophenyl, Or selenoxanthienyl. ≪ / RTI > In addition, the fluorenyl may include the spiro group described above.
본 출원의 일 실시상태에 따르면, 상기 R1 내지 R4는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴; 및 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, R1 to R4 are the same or different and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl; And substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroaryl.
본 출원의 일 실시상태에 따르면, 상기 R1 내지 R4는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C6 내지 C20의 단환 또는 다환의 아릴; 및 치환 또는 비치환된 C2 내지 C20의 단환 또는 다환의 헤테로아릴로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, R1 to R4 are the same or different and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C 6 to C 20 monocyclic or polycyclic aryl; And substituted or unsubstituted C 2 to C 20 monocyclic or polycyclic heteroaryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 1은 하기 화학식 2 내지 4 중 어느 하나로 표시될 수 있다.According to one embodiment of the present application, the formula (1) may be represented by any one of the following formulas (2) to (4).
본 출원의 일 실시상태에 따르면, 상기 t는 1 내지 3의 정수이다.According to one embodiment of the present application, t is an integer from 1 to 3.
본 출원의 일 실시상태에 따르면, 상기 t는 1이다.According to one embodiment of the present application, t is one.
[화학식 2](2)
[화학식 3](3)
[화학식 4][Chemical Formula 4]
상기 화학식 2 내지 4에 있어서, In the above formulas 2 to 4,
L1, L2, L3, t, R1, R2, R3, R4, m, n는 화학식 1에서 정의한 바와 동일하고,R 1, R 2, R 3, R 4, m and n are the same as defined in formula (1)
R5 및 R6는 화학식 1의 R1의 정의와 동일하다.R5 and R6 are the same as defined in R1 of formula (1).
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1 내지 R6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴; 및 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R1 to R6 are the same or different and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl; And substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroaryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1 내지 R6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 C6 내지 C20의 단환 또는 다환의 아릴; 및 치환 또는 비치환된 C2 내지 C20의 단환 또는 다환의 헤테로아릴로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R1 to R6 are the same or different and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted C 6 to C 20 monocyclic or polycyclic aryl; And substituted or unsubstituted C 2 to C 20 monocyclic or polycyclic heteroaryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1 내지 R6 중 적어도 하나는 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴; 또는 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴이다.According to one embodiment of the present application, in the general formulas 2 to 4, at least one of R 1 to R 6 is a substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl; Or a substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroaryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1 내지 R6 중 적어도 2개는 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴; 또는 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴이다.According to one embodiment of the present application, in the general formulas 2 to 4, at least two of R 1 to R 6 are substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl; Or a substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroaryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1 내지 R6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 및 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R1 to R6 are the same or different and each independently hydrogen; heavy hydrogen; And substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1, R2, R5 및 R6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 및 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R1, R2, R5 and R6 are the same or different and each independently hydrogen; heavy hydrogen; And substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R1, R2, R5 및 R6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소일 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R1, R2, R5 and R6 are the same or different and each independently hydrogen; It can be deuterium.
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R3 및 R4은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴일 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R 3 and R 4 may be the same or different and each independently a substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl .
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R3 및 R4은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6 내지 C20의 단환 또는 다환의 아릴일 수 있다.According to one embodiment of the present application, in the general formulas (2) to (4), R 3 and R 4 may be the same or different and each independently a substituted or unsubstituted C 6 to C 20 monocyclic or polycyclic aryl .
본 출원의 일 실시상태에 따르면, 상기 화학식 2 내지 4에 있어서, 상기 R3 및 R4은 페닐, 비페닐, 나프틸, 안트라세닐, 또는 페난트레닐일 수 있다.According to one embodiment of the present application, in the general formulas 2 to 4, R 3 and R 4 may be phenyl, biphenyl, naphthyl, anthracenyl, or phenanthrenyl.
본 출원의 일 실시상태에 따르면, 상기 화학식 1은 하기 화학식들로부터 선택될 수 있다.According to one embodiment of the present application, the formula (1) may be selected from the following formulas.
전술한 화합물들은 후술하는 제조예를 기초로 제조될 수 있다. 후술하는 제조예들에서는 대표적인 예시들을 기재하지만, 필요에 따라, 치환기를 추가하거나 제외할 수 있으며, 치환기의 위치를 변경할 수 있다. 또한, 당기술분야에 알려져 있는 기술을 기초로, 출발물질, 반응물질, 반응 조건 등을 변경할 수 있다. The above-mentioned compounds can be produced on the basis of the preparation examples described later. Exemplary examples are described below in the preparation examples, but substituents can be added or removed as needed, and the position of the substituent can be changed. In addition, based on techniques known in the art, starting materials, reactants, reaction conditions, and the like can be changed.
본 출원의 또 하나의 실시상태는 전술한 화학식 1의 화합물을 포함하는 유기발광소자를 제공한다. 구체적으로, 본 출원에 따른 유기발광소자는 양극, 음극 및 양극과 음극 사이에 구비된 1층 이상의 유기물층을 포함하고, 상기 유기물층 중 1층 이상은 상기 화학식 1의 화합물을 포함한다. Another embodiment of the present application provides an organic light emitting device comprising the compound of formula (1). Specifically, the organic light emitting device according to the present application includes a cathode, a cathode, and at least one organic layer provided between the anode and the cathode, and at least one of the organic layers includes the compound of Formula 1.
도 1 내지 3에 본 출원의 실시상태들에 따른 유기발광소자의 전극과 유기물층의 적층 순서를 예시하였다. 그러나, 이들 도면에 의하여 본 출원의 범위가 한정될 것을 의도한 것은 아니며, 당 기술분야에 알려져 있는 유기발광소자의 구조가 본 출원에도 적용될 수 있다. FIGS. 1 to 3 illustrate the stacking process of the electrodes and organic layers of the organic light emitting diode according to the embodiments of the present application. However, it is not intended that the scope of the present application be limited by these drawings, and the structure of the organic light emitting device known in the art can be applied to the present application.
도 1에 따르면, 기판(100) 상에 양극(200), 유기물층(300) 및 음극(400)이 순차적으로 적층된 유기발광소자가 도시된다. 그러나, 이와 같은 구조에만 한정되는 것은 아니고, 도 2와 같이, 기판 상에 음극, 유기물층 및 양극이 순차적으로 적층된 유기발광소자가 구현될 수도 있다. 1, an organic light emitting device in which an
도 3은 유기물층이 다층인 경우를 예시한 것이다. 도 3에 따른 유기발광소자는 정공주입층(301), 정공수송층(302), 발광층(303), 정공저지층(304), 전자수송층(305) 및 전자주입층(306)를 포함한다. 그러나, 이와 같은 적층구조에 의하여 본 출원의 범위가 한정되는 것은 아니며, 필요에 따라 발광층을 제외한 나머지 층은 생략될 수도 있고, 필요한 다른 기능층이 더 추가될 수 있다. FIG. 3 illustrates the case where the organic material layer is a multilayer. 3 includes a
본 출원에 따른 유기발광소자는 유기물층 중 1층 이상에 상기 화학식 1의 화합물을 포함하는 것을 제외하고는 당기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다. The organic light emitting device according to the present invention can be manufactured by materials and methods known in the art, except that at least one layer of the organic material layer contains the compound of the above formula (1).
상기 화학식 1의 화합물은 단독으로 유기발광소자의 유기물층 중 1층 이상을 구성할 수 있다. 그러나, 필요에 따라 다른 물질과 혼합하여 유기물층을 구성할 수도 있다. The compound of formula (I) may constitute one or more layers of the organic material layer of the organic light emitting device. However, if necessary, the organic material layer may be formed by mixing with other materials.
상기 화학식 1의 화합물은 유기발광소자에서 정공주입재료, 정공수송재료, 발광재료, 정공저지재료, 전자수송재료, 전자주입재료 등으로 사용될 수 있다. The compound of Formula 1 may be used as a hole injecting material, a hole transporting material, a light emitting material, a hole blocking material, an electron transporting material, and an electron injecting material in an organic light emitting device.
예컨대, 본 출원의 일 실시상태에 따른 화합물은 유기발광소자의 전자주입층, 전자수송층 또는 전자 주입과 수송을 동시에 하는 층의 재료로서 사용될 수 있다.For example, the compound according to one embodiment of the present application can be used as an electron injecting layer, an electron transporting layer, or a material of a layer which simultaneously injects electrons and transports the organic light emitting element.
또한, 본 출원의 일 실시상태에 따른 화합물은 유기발광소자의 발광층 재료로서 사용될 수 있다. 구체적으로, 상기 화합물은 단독으로 발광 재료로 사용될 수도 있고, 발광층의 호스트 재료 또는 도펀트 재료로서 사용될 수 있다.Further, the compound according to one embodiment of the present application can be used as a light emitting layer material of an organic light emitting device. Specifically, the compound can be used singly as a light emitting material, or as a host material or a dopant material in a light emitting layer.
또한, 본 출원의 일 실시상태에 따른 화합물은 유기발광소자의 인광 호스트 재료로서 사용될 수 있다. 이 경우, 본 출원의 일 실시상태에 따른 화합물은 인광 도펀트와 함께 포함된다.In addition, the compound according to one embodiment of the present application can be used as a phosphorescent host material of an organic light emitting device. In this case, the compound according to one embodiment of the present application is included with the phosphorescent dopant.
또한, 본 출원의 일 실시상태에 따른 화합물은 유기발광소자의 정공저지층의 재료로서 사용될 수 있다.In addition, the compound according to one embodiment of the present application can be used as a material for the hole blocking layer of the organic light emitting device.
본 출원에 따른 유기발광소자에 있어서, 상기 화학식 1의 화합물 이외의 재료를 하기에 예시하지만, 이들은 예시를 위한 것일 뿐 본 출원의 범위를 한정하기 위한 것은 아니며, 당 기술분야에 공지된 재료들로 대체될 수 있다. In the organic light emitting device according to the present application, materials other than the compound of Formula 1 are exemplified below, but they are for illustrative purposes only and are not intended to limit the scope of the present application and include materials known in the art Can be replaced.
양극 재료로는 비교적 일함수가 큰 재료들을 이용할 수 있으며, 투명 전도성 산화물, 금속 또는 전도성 고분자 등을 사용할 수 있다. As the cathode material, materials having a relatively large work function can be used, and a transparent conductive oxide, a metal, or a conductive polymer can be used.
음극 재료로는 비교적 일함수가 낮은 재료들을 이용할 수 있으며, 금속, 금속 산화물 또는 전도성 고분자 등을 사용할 수 있다. As the cathode material, materials having relatively low work functions can be used, and metals, metal oxides, conductive polymers, and the like can be used.
정공주입재료로는 공지된 정공주입재료를 이용할 수도 있는데, 예를 들면, 미국특허 제4,356,429호에 개시된 구리프탈로시아닌 등의 프탈로시아닌 화합물 또는 문헌 [Advanced Material, 6, p.677 (1994)]에 기재되어 있는 스타버스트형 아민 유도체류, 예컨대 TCTA, m-MTDATA, m-MTDAPB, 용해성이 있는 전도성 고분자인 Pani/DBSA(Polyaniline/Dodecylbenzenesulfonic acid: 폴리아닐린/도데실벤젠술폰산) 또는 PEDOT/PSS(Poly(3,4-ethylenedioxythiophene)/Poly(4-styrenesulfonate):폴리(3,4-에틸렌디옥시티오펜)/폴리(4-스티렌술포네이트)), Pani/CSA(Polyaniline/Camphor sulfonic acid:폴리아닐린/캠퍼술폰산) 또는 PANI/PSS(Polyaniline/Poly(4-styrene-sulfonate):폴리아닐린/폴리(4-스티렌술포네이트)) 등을 사용할 수 있다.As the hole injecting material, a known hole injecting material may be used. For example, a phthalocyanine compound such as copper phthalocyanine disclosed in U.S. Patent No. 4,356,429 or a compound described in Advanced Material, 6, p. 677 (1994) PANDOT / PSS (Polyaniline / Dodecylbenzenesulfonic acid), which is a soluble conductive polymer such as TCA, m-MTDATA, m-MTDAPB, 4-ethylenedioxythiophene / poly (4-styrenesulfonate) / poly (4-styrene sulfonate) / Pani / CSA (polyaniline / camphor sulfonic acid) PANI / PSS (polyaniline / poly (4-styrene-sulfonate): polyaniline / poly (4-styrenesulfonate)).
정공수송재료로는 피라졸린 유도체, 아릴아민계 유도체, 스틸벤 유도체, 트리페닐디아민 유도체 등이 사용될 수 있으며, 저분자 또는 고분자 재료가 사용될 수도 있다. As the hole transporting material, a pyrazoline derivative, an arylamine derivative, a stilbene derivative, a triphenyldiamine derivative, or the like may be used, and a low molecular weight or a high molecular weight material may be used.
전자수송재료로는 옥사디아졸 유도체, 안트라퀴노디메탄 및 이의 유도체, 벤조퀴논 및 이의 유도체, 나프토퀴논 및 이의 유도체, 안트라퀴논 및 이의 유도체, 테트라시아노안트라퀴노디메탄 및 이의 유도체, 플루오레논 유도체, 디페닐디시아노에틸렌 및 이의 유도체, 디페노퀴논 유도체, 8-히드록시퀴놀린 및 이의 유도체의 금속 착체 등이 사용될 수 있으며, 저분자 물질 뿐만 아니라 고분자 물질이 사용될 수도 있다. Examples of the electron transporting material include oxadiazole derivatives, anthraquinodimethane and derivatives thereof, benzoquinone and derivatives thereof, naphthoquinone and derivatives thereof, anthraquinone and derivatives thereof, tetracyanoanthraquinodimethane and derivatives thereof, Derivatives thereof, diphenyldicyanoethylene and derivatives thereof, diphenoquinone derivatives, metal complexes of 8-hydroxyquinoline and derivatives thereof, and the like may be used as well as low molecular weight materials and high molecular weight materials.
전자주입재료로는 예를 들어, LiF가 당업계 대표적으로 사용되나, 본 출원이 이에 한정되는 것은 아니다. As the electron injecting material, for example, LiF is typically used in the art, but the present application is not limited thereto.
발광재료로는 적색, 녹색 또는 청색 발광재료가 사용될 수 있으며, 필요한 경우 2 이상의 발광재료를 혼합하여 사용할 수 있다. 또한, 발광재료로서 형광 재료를 사용할 수도 있으나, 인광 재료를 사용할 수도 있다. 발광재료로는 단독으로서 양극과 음극으로부터 각각 주입된 정공과 전자를 결합하여 발광시키는 재료가 사용될 수도 있으나, 호스트 재료와 도펀트 재료가 함께 발광에 관여하는 재료들이 사용될 수도 있다. As the light emitting material, red, green or blue light emitting materials may be used, and if necessary, two or more light emitting materials may be mixed and used. Further, a fluorescent material may be used as the light emitting material, but a phosphorescent material may also be used. As the light emitting material, a material which emits light by coupling holes and electrons respectively injected from the anode and the cathode may be used. However, materials in which both the host material and the dopant material participate in light emission may also be used.
본 출원에 따른 화합물이 인광 호스트 재료로서 사용되는 경우, 함께 사용되는 인광 도펀트 재료로는 당기술분야에 알려져 있는 것들을 사용할 수 있다. When the compound according to the present application is used as a phosphorescent host material, phosphorescent dopant materials used together can be those known in the art.
예컨대, LL'MX, LL'L"M, LMXX', L2MX 및 L3M로 표시되는 인광 도펀트 재료를 사용할 수 있으나, 이들 예에 의하여 본 출원의 범위가 한정되는 것은 아니다.For example, phosphorescent dopant materials represented by LL'MX, LL'L "M, LMXX ', L 2 MX and L 3 M can be used, but the scope of the present application is not limited by these examples.
여기서, L, L', L", X 및 X'는 서로 상이한 2좌 배위자이고, M은 8 면상 착체를 형성하는 금속이다. Here, L, L ', L ", X and X' are two different left ligands and M is a metal forming an octahedral complex.
M은 이리듐, 백금, 오스뮴 등이 될 수 있다. M may be iridium, platinum, osmium, and the like.
L은 sp2 탄소 및 헤테로 원자에 의하여 M에 배위되는 음이온성 2좌 배위자이고, X는 전자 또는 정공을 트랩하는 기능을 할 수 있다. L의 비한정적인 예로는 2-(1-나프틸)벤즈옥사졸, (2-페닐벤즈옥사졸), (2-페닐벤조티아졸), (7,8-벤조퀴놀린), (티에닐피리진), 페닐피리딘, 벤조티에닐피리진, 3-메톡시-2-페닐피리딘, 티에닐피리진, 톨릴피리딘 등이 있다. X의 비한정적인 예로는 아세틸아세토네이트(acac), 헥사플루오로아세틸아세토네이트, 살리실리덴, 피콜리네이트, 8-히드록시퀴놀리네이트 등이 있다. L is sp 2 An anionic bidentate ligand that is coordinated to M by carbon and hetero atoms, and X can function to trap electrons or holes. Non-limiting examples of L include 2- (1-naphthyl) benzoxazole, (2-phenylbenzoxazole), (2-phenylbenzothiazole), (7,8-benzoquinoline) Phenyl) pyridine, benzothienylpyridine, 3-methoxy-2-phenylpyridine, thienylpyridine, tolylpyridine and the like. Non-limiting examples of X include acetylacetonate (acac), hexafluoroacetylacetonate, salicylidene, picolinate, 8-hydroxyquinolinate, and the like.
더욱 구체적인 예를 하기에 표시하나, 이들 예로만 한정되는 것은 아니다.More specific examples are shown below, but are not limited to these examples.
이하에서, 실시예를 통하여 본 출원을 더욱 상세하게 설명하지만, 이들은 본 출원을 예시하기 위한 것일 뿐, 본 출원의 범위를 한정하기 위한 것은 아니다.
Hereinafter, the present application will be described in more detail by way of examples, but these are for the purpose of illustrating the present application and are not intended to limit the scope of the present application.
[제조예 1] 하기 표 1의 치환기를 갖는 화합물의 제조[Preparation Example 1] Preparation of a compound having a substituent shown in the following Table 1
화합물 1-1의 제조Preparation of Compound 1-1
메틸-2-브로모벤조에이트(methyl 2-bromobenzoate) (1 eq.)을 THF(tetrahydrofuran) 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 아세토페논(acetophenone) (1 eq.)을 천천히 적가한 후, 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 종결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액 및 H2O를 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 1-1를 얻었다. Methyl 2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF (tetrahydrofuran), followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, acetophenone (1 eq.) Was slowly added dropwise, followed by stirring at room temperature for 2 hours and heating at 100 ° C for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1N HCl, aqueous NaHCO 3 solution, and H 2 O. The extract was separated and purified by column chromatography to obtain Compound 1-1.
화합물 1-2의 제조Preparation of Compound 1-2
화합물 1-1 (1eq.)를 DMF(dimethylformamide) 160 mL에 녹인 후, H2NNH2ㆍH2O (1.1 eq.)를 넣고 상온에서 6시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 1-2를 얻었다.Compound 1-1 (1 eq.) Was dissolved in 160 mL of DMF, followed by addition of H 2 NNH 2 .H 2 O (1.1 eq.) And the mixture was stirred at room temperature for 6 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain a compound 1-2.
화합물 1-3의 제조Preparation of compounds 1-3
화합물 1-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 4-브로모벤젠알데하이드(4-bromobenzaldehyde) (1.2 eq.)을 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 1-3을 얻었다.Compound 1-2 (1 eq.) Was dissolved in DMF (240 mL), CuI (0.1 eq.) And 4-bromobenzaldehyde (1.2 eq.) Were added and stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain Compound 1-3.
화합물 1-4의 제조Preparation of compounds 1-4
화합물 1-3 (1 eq.)를 DMF 60 mL에 녹인 후, CuI (0.1 eq.) 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 1-4을 얻었다.Compound 1-3 (1 eq.) Was dissolved in 60 mL of DMF, CuI (0.1 eq.) Was added, and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain the compound 1-4.
화합물 1-5의 제조Preparation of compounds 1-5
화합물 1-4 (1 eq.)을 DMF 300 mL에 녹인 후 2,2,3,3,7,7,8,8-옥타메틸-1,4,6,9-테트라옥사-5l4-보라스피로[4.4]노네인(2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-5l4-boraspiro[4.4]nonane) (2 eq.), PdCl2(dppf) (0.05eq.), KOAc (3 eq.)을 넣고 80℃에서 24시간 교반하였다. 반응이 종결되면 디클로로메탄(dichloromethane)과 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 1-5을 얻었다.Compound 1-4 (1 eq.) Was dissolved in 300 mL of DMF, and then 2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-514- [4.4] nonane (2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-5l4-boraspiro [4.4] nonane) (2 eq.), PdCl 2 (dppf) (0.05 eq.) and KOAc (3 eq.) were added, and the mixture was stirred at 80 ° C for 24 hours. After the reaction was completed, dichloromethane and H 2 O were extracted. The extract was separated and purified by column chromatography to obtain a compound 1-5.
화합물 compound P1P1 의 제조Manufacturing
화합물 1-5 (2.2 eq.)를 톨루엔/에탄올/ H2O = 5:1:1의 비율에 녹인 후, Pd(PPh3)4 (0.05 eq.), K2CO3 (3eq.), 화합물 S-1 (1 eq.)을 넣고 4시간 가열하였다. 반응이 종결되면 디클로로메탄(dichloromethane)과 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 목적화합물 P1을 얻었다.The compound 1-5 (2.2 eq.) Was dissolved in toluene / ethanol / H 2 O = 5: 1: 1 and then Pd (PPh 3 ) 4 (0.05 eq.), K 2 CO 3 (3 eq. Compound S-1 (1 eq.) Was added and heated for 4 hours. After the reaction was completed, dichloromethane and H 2 O were extracted. The extract was separated and purified by column chromatography to obtain the desired compound P1.
상기 제조예 1에서, S-1의 Ar을 하기 표 1과 같이 적용하여 화합물 1 내지 20을 제조하였다.In Preparation Example 1, Ar of S-1 was applied as shown in Table 1 below to prepare Compounds 1 to 20.
[제조예 2] 하기 표 2의 치환기를 갖는 화합물의 제조[Preparation Example 2] Preparation of a compound having a substituent shown in the following Table 2
화합물 2-3의 제조Preparation of Compound 2-3
화합물 1-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 3-브로모벤젠알데하이드(3-bromobenzaldehyde) (1.2 eq.)을 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 2-3을 얻었다.Compound 1-2 (1 eq.) Was dissolved in 240 mL of DMF, CuI (0.1 eq.) And 3-bromobenzaldehyde (1.2 eq.) Were added and stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain Compound 2-3.
화합물 2-4의 제조Preparation of compound 2-4
화합물 1-3 대신 화합물 2-3을 사용한 것을 제외하고는, 제조예 1에서의 1-4의 제조와 동일한 방법으로 제조하여 화합물 2-4를 얻었다.Compound 2-4 was obtained in the same manner as in the production of 1-4 in Preparative Example 1 except that Compound 2-3 was used instead of Compound 1-3.
화합물 2-5의 제조Preparation of Compound 2-5
화합물 1-4 대신 화합물 2-4를 사용한 것을 제외하고는, 제조예 1에서의 1-5의 제조와 동일한 방법으로 제조하여 화합물 2-5를 얻었다.Compound 2-5 was obtained in the same manner as in the production of 1-5 in Production Example 1 except that Compound 2-4 was used instead of Compound 1-4.
화합물 compound P2P2 의 제조Manufacturing
화합물 1-5 대신 화합물 2-5를 사용한 것을 제외하고는, 제조예 1에서의 P1의 제조와 동일한 방법으로 제조하여 목적화합물 P2를 얻었다. The target compound P2 was obtained in the same manner as in the production of P1 in Production Example 1, except that the compound 2-5 was used instead of the compound 1-5.
상기 제조예 2에서, S-1의 Ar을 하기 표 2와 같이 적용하여 화합물 26 및 45를 제조하였다.In Preparation Example 2, Ar of S-1 was applied as shown in Table 2 below to prepare compounds 26 and 45.
[제조예 3] 하기 표 3의 치환기를 갖는 화합물의 제조[Preparation Example 3] Preparation of a compound having a substituent shown in the following Table 3
화합물 3-3의 제조Preparation of compound 3-3
화합물 1-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 6-브로모-2-나프트알데하이드(6-bromo-2-naphthaldehyde) (1.2 eq.)를 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 3-3을 얻었다.Compound 1-2 (1 eq.) Was dissolved in 240 mL of DMF and CuI (0.1 eq.) And 6-bromo-2-naphthaldehyde (1.2 eq.) And the mixture was stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain the compound 3-3.
화합물 3-4의 제조Preparation of compound 3-4
화합물 1-3 대신 화합물 3-3을 사용한 것을 제외하고는, 제조예 1에서의 1-4의 제조와 동일한 방법으로 제조하여 화합물 3-4를 얻었다.Compound 3-4 was obtained in the same manner as in the production of 1-4 in Production Example 1 except that Compound 3-3 was used instead of Compound 1-3.
화합물 3-5의 제조Preparation of Compound 3-5
화합물 1-4 대신 화합물 3-4를 사용한 것을 제외하고는, 제조예 1에서의 1-5의 제조와 동일한 방법으로 제조하여 화합물 3-5를 얻었다.Compound 3-5 was obtained in the same manner as in the production of 1-5 in Production Example 1 except that Compound 3-4 was used instead of Compound 1-4.
화합물 compound P3P3 의 제조Manufacturing
화합물 1-5 대신 화합물 3-5를 사용한 것을 제외하고는, 제조예 1에서의 P1의 제조와 동일한 방법으로 제조하여 목적화합물 P3를 얻었다. The procedure of Production Example 1 was repeated except that Compound 3-5 was used instead of Compound 1-5 to obtain the target compound P3.
상기 제조예 3에서, S-1의 Ar을 하기 표 3과 같이 적용하여 화합물 21 내지 23을 제조하였다.In Preparation Example 3, Ar of S-1 was applied as shown in Table 3 below to prepare Compounds 21 to 23.
[제조예 4] 하기 표 4의 치환기를 갖는 화합물의 제조[Preparation Example 4] Preparation of a compound having a substituent shown in the following Table 4
화합물 4-3의 제조Preparation of compound 4-3
화합물 1-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 5-브로모피콜린알데하이드(5-bromopicolinaldehyde) (1.2 eq.)을 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 1-3을 얻었다.Compound 1-2 (1 eq.) Was dissolved in 240 mL of DMF. CuI (0.1 eq.) And 5-bromopicolinaldehyde (1.2 eq.) Were added thereto and stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain Compound 1-3.
화합물 4-4의 제조Preparation of compound 4-4
화합물 1-3 대신 화합물 4-3을 사용한 것을 제외하고는, 제조예 1에서의 1-4의 제조와 동일한 방법으로 제조하여 화합물 4-4를 얻었다.Compound 4-4 was obtained in the same manner as in the production of 1-4 in Production Example 1, except that Compound 4-3 was used instead of Compound 1-3.
화합물 4-5의 제조Preparation of Compound 4-5
화합물 1-4 대신 화합물 4-4를 사용한 것을 제외하고는, 제조예 1에서의 1-5의 제조와 동일한 방법으로 제조하여 화합물 4-5를 얻었다.Compound 4-5 was obtained in the same manner as in the production of 1-5 in Production Example 1 except that Compound 4-4 was used in place of Compound 1-4.
화합물 compound P4P4 의 제조Manufacturing
화합물 1-5 대신 화합물 4-5를 사용한 것을 제외하고는, 제조예 1에서의 P1의 제조와 동일한 방법으로 제조하여 목적화합물 P4를 얻었다. The procedure of Production Example 1 was repeated except that Compound 4-5 was used instead of Compound 1-5 to obtain the desired compound P4.
상기 제조예 4에서, S-1의 Ar을 하기 표 4와 같이 적용하여 화합물 24 및 25를 제조하였다.In Preparation Example 4, Ar of S-1 was applied as shown in Table 4 to prepare Compounds 24 and 25.
[제조예 5] 하기 표 5의 치환기를 갖는 화합물의 제조[Preparation Example 5] Preparation of a compound having a substituent shown in the following Table 5
화합물 5-1의 제조Preparation of Compound 5-1
메틸-2-브로모벤조에이트(methyl-2-bromobenzoate) (1 eq.)을 THF 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 4-브로모아세토페논(4-bromoacetophenone) (1 eq.)을 천천히 적가하였다. 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 완결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액, H2O을 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 5-1을 얻었다. Methyl-2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF, followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, 4-bromoacetophenone (1 eq.) Was slowly added dropwise. The mixture was stirred at room temperature for 2 hours and heated at 100 占 폚 for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1N HCl, aqueous NaHCO 3 solution, and H 2 O. The extract was separated and purified by column chromatography to obtain Compound 5-1.
화합물 5-2의 제조Preparation of Compound 5-2
화합물 5-1 (1eq.)를 DMF 160 mL에 녹인 후, H2NNH2ㆍH2O (1.1 eq.)를 넣고 상온에서 6시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 5-2를 얻었다.Compound 5-1 (1 eq.) Was dissolved in 160 mL of DMF, followed by addition of H 2 NNH 2 .H 2 O (1.1 eq.) And the mixture was stirred at room temperature for 6 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain Compound 5-2.
화합물 5-3의 제조Preparation of Compound 5-3
화합물 5-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 벤즈알데하이드(benzaldehyde) (1.2 eq.)을 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 5-3을 얻었다.Compound 5-2 (1 eq.) Was dissolved in DMF (240 mL), CuI (0.1 eq.) And benzaldehyde (1.2 eq.) Were added and stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain a compound 5-3.
화합물 5-4의 제조Preparation of compound 5-4
화합물 5-3 (1 eq.)를 DMF 60 mL에 녹인 후, CuI (0.1 eq.) 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 5-4를 얻었다.Compound 5-3 (1 eq.) Was dissolved in 60 mL of DMF, CuI (0.1 eq.) Was added, and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain a compound 5-4.
화합물 5-5의 제조Preparation of Compound 5-5
화합물 5-4 (1 eq.)을 DMF 300 mL에 녹인 후 2,2,3,3,7,7,8,8-옥타메틸-1,4,6,9-테트라옥사-5l4-보라스피로[4.4]노네인(2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-5l4-boraspiro[4.4]nonane) (2 eq.), PdCl2(dppf) (0.05eq.), KOAc (3 eq.)을 넣고 80℃에서 24시간 교반하였다. 반응이 종결되면 디클로로메탄(dichloromethane)과 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 5-5를 얻었다.Compound 5-4 (1 eq.) Was dissolved in 300 mL of DMF, and then 2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-514- [4.4] nonane (2,2,3,3,7,7,8,8-octamethyl-1,4,6,9-tetraoxa-5l4-boraspiro [4.4] nonane) (2 eq.), PdCl2 dppf) (0.05 eq.) and KOAc (3 eq.) were added, and the mixture was stirred at 80 占 폚 for 24 hours. After the reaction was completed, dichloromethane and H 2 O were extracted. The extract was separated and purified by column chromatography to obtain Compound 5-5.
화합물 compound P5P5 의 제조Manufacturing
화합물 5-5 (2.2 eq.)를 톨루엔/에탄올/ H2O = 5:1:1의 비율에 녹인 후, Pd(PPh3)4 (0.05 eq.), K2CO3 (3eq.), 화합물 S-1 (1 eq.)을 넣고 4시간 가열하였다. 반응이 종결되면 디클로로메탄(dichloromethane)과 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 목적화합물 P5를 얻었다.Compound 5-5 (. 2.2 eq) in toluene / ethanol / H 2 O = 5: 1 : was dissolved in the proportion of 1, Pd (PPh 3) 4 (. 0.05 eq), K2CO3 (. 3eq), the compound S- 1 (1 eq.) And heated for 4 hours. After the reaction was completed, dichloromethane and H 2 O were extracted. The extract was separated and purified by column chromatography to obtain the desired compound P5.
상기 제조예 5에서, S-1의 Ar을 하기 표 5와 같이 적용하여 화합물 51 및 70을 제조하였다.In Preparation Example 5, compounds of 51 and 70 were prepared by applying Ar of S-1 as shown in Table 5 below.
[제조예 6] 하기 표 6의 치환기를 갖는 화합물의 제조[Preparation Example 6] Preparation of a compound having a substituent shown in the following Table 6
화합물 6-1의 제조Preparation of Compound 6-1
메틸-2-브로모벤조에이트(methyl-2-bromobenzoate) (1 eq.)를 THF 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 3-브로모아세토페논(3-bromoacetophenone) (1 eq.)을 천천히 적가하였다. 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 완결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액, H2O를 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 6-1를 얻었다. Methyl-2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF, followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, 3-bromoacetophenone (1 eq.) Was slowly added dropwise. The mixture was stirred at room temperature for 2 hours and heated at 100 占 폚 for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1 N HCl, aqueous NaHCO 3 solution and H 2 O. The extract was separated and purified by column chromatography to obtain 6-1.
화합물 6-2의 제조Preparation of Compound 6-2
화합물 5-1 대신 화합물 6-1을 사용한 것을 제외하고는, 제조예 5에서의 5-2의 제조와 동일한 방법으로 제조하여 화합물 6-2를 얻었다. Compound 6-2 was obtained in the same manner as in the production of 5-2 in Production Example 5 except that Compound 6-1 was used instead of Compound 5-1.
화합물 6-3의 제조Preparation of Compound 6-3
화합물 5-2 대신 화합물 6-2를 사용한 것을 제외하고는, 제조예 5에서의 5-3의 제조와 동일한 방법으로 제조하여 화합물 6-3을 얻었다. Compound 6-2 was prepared in the same manner as in the production of 5-3 in Production Example 5, except that Compound 6-2 was used instead of Compound 5-2.
화합물 6-4의 제조Preparation of Compound 6-4
화합물 5-3 대신 화합물 6-3을 사용한 것을 제외하고는, 제조예 5에서의 5-4의 제조와 동일한 방법으로 제조하여 화합물 6-4를 얻었다. Compound 6-3 was prepared in the same manner as in the production of 5-4 in Production Example 5 except that Compound 6-3 was used instead of Compound 5-3.
화합물 6-5의 제조Preparation of Compound 6-5
화합물 5-4 대신 화합물 6-4을 사용한 것을 제외하고는, 제조예 5에서의 5-5의 제조와 동일한 방법으로 제조하여 화합물 6-5를 얻었다. Compound 6-5 was obtained in the same manner as in the production of 5-5 in Production Example 5, except that Compound 6-4 was used instead of Compound 5-4.
화합물 compound P6P6 의 제조Manufacturing
화합물 5-5 대신 화합물 6-5를 사용한 것을 제외하고는, 제조예 5에서의 P5의 제조와 동일한 방법으로 제조하여 화합물 P6을 얻었다. Compound P6 was obtained in the same manner as in the production of P5 in Production Example 5 except that Compound 6-5 was used instead of Compound 5-5.
상기 제조예 6에서, S-1의 Ar을 하기 표 6과 같이 적용하여 화합물 76 내지 95를 제조하였다.In Preparation Example 6, Ar of S-1 was applied as shown in the following Table 6 to prepare Compounds 76 to 95.
[제조예 7] 하기 표 7의 치환기를 갖는 화합물의 제조[Preparation Example 7] Preparation of a compound having a substituent shown in the following Table 7
화합물 7-1의 제조Preparation of Compound 7-1
메틸-2-브로모벤조에이트(methyl-2-bromobenzoate) (1 eq.)을 THF 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 1-(6-브로모나프탈렌-2-일)에탄-1-온(1-(6-bromonaphthalen-2-yl)ethan-1-one) (1 eq.)을 천천히 적가하였다. 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 완결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액, H2O을 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 7-1를 얻었다. Methyl-2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF, followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, 1- (6-bromonaphthalen-2-yl) ethan-1-one (1 eq.) Was slowly added dropwise. The mixture was stirred at room temperature for 2 hours and heated at 100 占 폚 for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1N HCl, aqueous NaHCO 3 solution, and H 2 O. The extract was separated and purified by column chromatography to obtain 7-1.
화합물 7-2의 제조Preparation of Compound 7-2
화합물 5-1 대신 화합물 7-1을 사용한 것을 제외하고는, 제조예 5에서의 5-2의 제조와 동일한 방법으로 제조하여 화합물 7-2를 얻었다. Compound 7-2 was obtained in the same manner as in the production of 5-2 in Production Example 5, except that Compound 7-1 was used instead of Compound 5-1.
화합물 7-3의 제조Preparation of Compound 7-3
화합물 5-2 대신 화합물 7-2를 사용한 것을 제외하고는, 제조예 5에서의 5-3의 제조와 동일한 방법으로 제조하여 화합물 7-3을 얻었다. Compound 7-2 was prepared in the same manner as in the production of 5-3 in Production Example 5, except that Compound 7-2 was used instead of Compound 5-2.
화합물 7-4의 제조Preparation of Compound 7-4
화합물 5-3 대신 화합물 7-3을 사용한 것을 제외하고는, 제조예 5에서의 5-4의 제조와 동일한 방법으로 제조하여 화합물 7-4를 얻었다. Compound 7-4 was obtained in the same manner as in the production of 5-4 in Production Example 5, except that Compound 7-3 was used instead of Compound 5-3.
화합물 7-5의 제조Preparation of Compound 7-5
화합물 5-4 대신 화합물 7-4을 사용한 것을 제외하고는, 제조예 5에서의 5-5의 제조와 동일한 방법으로 제조하여 화합물 7-5를 얻었다. Compound 7-5 was obtained in the same manner as in the production of 5-5 in Production Example 5, except that Compound 7-4 was used instead of Compound 5-4.
화합물 compound P7P7 의 제조Manufacturing
화합물 5-5 대신 화합물 7-5를 사용한 것을 제외하고는, 제조예 5에서의 P5의 제조와 동일한 방법으로 제조하여 화합물 P7을 얻었다.Compound P7 was obtained in the same manner as in the production of P5 in Production Example 5 except that Compound 7-5 was used instead of Compound 5-5.
상기 제조예 7에서, S-1의 Ar을 하기 표 7과 같이 적용하여 화합물 71 내지 73을 제조하였다.In Preparation Example 7, Ar of S-1 was applied as shown in Table 7 below to prepare compounds 71 to 73.
[제조예 8] 하기 표 8의 치환기를 갖는 화합물의 제조[Preparation Example 8] Preparation of a compound having a substituent shown in the following Table 8
화합물 8-1의 제조Preparation of Compound 8-1
메틸-2-브로모벤조에이트(methyl-2-bromobenzoate) (1 eq.)을 THF 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 1-(5-브로모피리딘-2-일)에탄-1-온(1-(5-bromopyridin-2-yl)ethan-1-one) (1 eq.)을 천천히 적가하였다. 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 완결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액, H2O를 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 8-1를 얻었다. Methyl-2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF, followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, 1- (5-bromopyridin-2-yl) ethan-1-one (1 eq.) Was slowly added dropwise. The mixture was stirred at room temperature for 2 hours and heated at 100 占 폚 for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1 N HCl, aqueous NaHCO 3 solution and H 2 O. The extract was separated and purified by column chromatography to obtain 8-1.
화합물 8-2의 제조Preparation of Compound 8-2
화합물 5-1 대신 화합물 8-1을 사용한 것을 제외하고는, 제조예 5에서의 5-2의 제조와 동일한 방법으로 제조하여 화합물 8-2를 얻었다. Compound 8-2 was obtained in the same manner as in the production of 5-2 in Production Example 5 except that Compound 8-1 was used instead of Compound 5-1.
화합물 8-3의 제조Preparation of Compound 8-3
화합물 5-2 대신 화합물 8-2를 사용한 것을 제외하고는, 제조예 5에서의 5-3의 제조와 동일한 방법으로 제조하여 화합물 8-3을 얻었다. Compound 8-3 was obtained in the same manner as in the production of 5-3 in Production Example 5, except that Compound 8-2 was used instead of Compound 5-2.
화합물 8-4의 제조Preparation of Compound 8-4
화합물 5-3 대신 화합물 8-3을 사용한 것을 제외하고는, 제조예 5에서의 5-4의 제조와 동일한 방법으로 제조하여 화합물 8-4를 얻었다. Compound 8-4 was obtained in the same manner as in the production of 5-4 in Production Example 5, except that Compound 8-3 was used instead of Compound 5-3.
화합물 8-5의 제조Preparation of Compound 8-5
화합물 5-4 대신 화합물 8-4을 사용한 것을 제외하고는, 제조예 5에서의 5-5의 제조와 동일한 방법으로 제조하여 화합물 8-5를 얻었다. Compound 8-4 was obtained in the same manner as in the production of 5-5 in Production Example 5, except that Compound 8-4 was used instead of Compound 5-4.
화합물 compound P8P8 의 제조Manufacturing
화합물 5-5 대신 화합물 8-5를 사용한 것을 제외하고는, 제조예 5에서의 P5의 제조와 동일한 방법으로 제조하여 화합물 P8을 얻었다.Compound P5 was obtained in the same manner as in the production of P5 in Production Example 5, except that Compound 8-5 was used instead of Compound 5-5.
상기 제조예 8에서, S-1의 Ar을 하기 표 8과 같이 적용하여 화합물 74 및 75를 제조하였다.In Preparation Example 8, Ar of S-1 was applied as shown in Table 8 below to prepare Compounds 74 and 75.
[제조예 9] 하기 표 9의 치환기를 갖는 화합물의 제조[Preparation Example 9] Preparation of a compound having a substituent shown in the following Table 9
화합물 compound P9P9 의 제조Manufacturing
화합물 1-5 (1.1 eq.)를 톨루엔/에탄올/H2O = 5:1:1의 비율에 녹인 후, Pd(PPh3)4 (0.05 eq.), K2CO3 (3eq.), 화합물 S-1 (3 eq.)을 넣고 교반한 후, 화합물 5-5 (1.1 eq.)을 첨가한 후 4시간 가열하였다. 반응이 종결된 후 디클로로메탄과 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 P9을 얻었다.The compound 1-5 (1.1 eq.) Was dissolved in a toluene / ethanol / H 2 O ratio of 5: 1: 1 and then Pd (PPh 3 ) 4 (0.05 eq.), K 2 CO 3 (3 eq. Compound S-1 (3 eq.) Was added and stirred. Compound 5-5 (1.1 eq.) Was added and heated for 4 hours. After the reaction was completed, the reaction mixture was extracted with dichloromethane and H 2 O. The extract was separated and purified by column chromatography to obtain a compound P9.
상기 제조예 9에서, S-1의 Ar을 하기 표 9와 같이 적용하여 화합물 101 내지 110을 제조하였다.In Preparation Example 9, Ar of S-1 was applied as shown in Table 9 to prepare Compounds 101 to 110.
[제조예 10] 하기 표 10의 치환기를 갖는 화합물의 제조[Preparation Example 10] Preparation of a compound having a substituent shown in the following Table 10
화합물 10-3의 제조Preparation of compound 10-3
화합물 1-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 5-브로모-2-나프트알데하이드(5-bromo-2-naphthaldehyde) (1.2 eq.)를 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 10-3을 얻었다.Compound 1-2 (1 eq.) Was dissolved in 240 mL of DMF and CuI (0.1 eq.) And 5-bromo-2-naphthaldehyde (1.2 eq.) And the mixture was stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain Compound 10-3.
화합물 10-4의 제조Preparation of Compound 10-4
화합물 1-3 대신 화합물 10-3을 사용한 것을 제외하고는, 제조예 1에서의 1-4의 제조와 동일한 방법으로 제조하여 화합물 10-4를 얻었다.Compound 10-4 was obtained in the same manner as in the production of 1-4 in Production Example 1, except that Compound 10-3 was used instead of Compound 1-3.
화합물 10-5의 제조Preparation of Compound 10-5
화합물 1-4 대신 화합물 10-4를 사용한 것을 제외하고는, 제조예 1에서의 10-5의 제조와 동일한 방법으로 제조하여 화합물 10-5를 얻었다.Compound 10-5 was obtained in the same manner as in the production of 10-5 in Production Example 1, except that Compound 10-4 was used instead of Compound 1-4.
화합물 compound P10P10 의 제조Manufacturing
화합물 1-5 대신 화합물 10-5를 사용한 것을 제외하고는, 제조예 1에서의 P1의 제조와 동일한 방법으로 제조하여 목적화합물 P10을 얻었다.The procedure of Production Example 1 was repeated except that Compound 10-5 was used instead of Compound 1-5 to obtain the target compound P10.
상기 제조예 10에서, S-1의 Ar을 하기 표 10과 같이 적용하여 화합물 46 내지 48을 제조하였다.In Preparation Example 10, Ar of S-1 was applied as shown in Table 10 below to prepare Compounds 46 to 48.
[제조예 11] 하기 표 11의 치환기를 갖는 화합물의 제조 [Preparation Example 11] Preparation of a compound having a substituent shown in the following Table 11
화합물 11-3의 제조Preparation of Compound 11-3
화합물 1-2 (1 eq.)를 DMF 240 mL에 녹인 후, CuI (0.1 eq.), 4-브로모피콜린알데하이드(4-bromopicolinaldehyde) (1.2 eq.)을 넣고 30분 교반하였다. 교반 후 NH3ㆍH2O 66 mL를 넣고 100℃에서 24시간 교반하였다. 반응이 종결되면 에틸아세테이트(ethyl acetate)와 H2O로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 화합물 11-3을 얻었다.Compound 1-2 (1 eq.) Was dissolved in 240 mL of DMF. CuI (0.1 eq.) And 4-bromopicolinaldehyde (1.2 eq.) Were added thereto and stirred for 30 minutes. After stirring, 66 mL of NH 3 .H 2 O was added and the mixture was stirred at 100 ° C for 24 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate and H 2 O. [ The extract was separated and purified by column chromatography to obtain Compound 11-3.
화합물 11-4의 제조Preparation of Compound 11-4
화합물 1-3 대신 화합물 4-3을 사용한 것을 제외하고는, 제조예 1에서의 1-4의 제조와 동일한 방법으로 제조하여 화합물 11-4를 얻었다.Compound 11-4 was obtained in the same manner as in the production of 1-4 in Production Example 1, except that Compound 4-3 was used instead of Compound 1-3.
화합물 11-5의 제조Preparation of Compound 11-5
화합물 1-4 대신 화합물 4-4를 사용한 것을 제외하고는, 제조예 1에서의 1-5의 제조와 동일한 방법으로 제조하여 화합물 11-5를 얻었다.Compound 11-5 was obtained in the same manner as in the production of 1-5 in Preparative Example 1, except that Compound 4-4 was used in place of Compound 1-4.
화합물 compound P11P11 의 제조Manufacturing
화합물 1-5 대신 화합물 4-5를 사용한 것을 제외하고는, 제조예 1에서의 P1의 제조와 동일한 방법으로 제조하여 목적화합물 P11를 얻었다.The target compound P11 was obtained in the same manner as in the production of P1 in Production Example 1 except that the compound 4-5 was used instead of the compound 1-5.
상기 제조예 11에서, S-1의 Ar을 하기 표 11과 같이 적용하여 화합물 49 및 50을 제조하였다.In Preparation Example 11, Ar of S-1 was applied as shown in the following Table 11 to prepare Compounds 49 and 50.
[제조예 12] 하기 표 12의 치환기를 갖는 화합물의 제조 [Preparation Example 12] Preparation of a compound having a substituent shown in the following Table 12
화합물 12-1의 제조Preparation of Compound 12-1
메틸-2-브로모벤조에이트(methyl-2-bromobenzoate) (1 eq.)을 THF 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 1-(4-브로모피리딘-2-일)에탄-1-온(1-(4-bromopyridin-2-yl)ethan-1-one) (1 eq.)을 천천히 적가하였다. 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 완결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액, H2O를 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 12-1를 얻었다. Methyl-2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF, followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, 1- (4-bromopyridin-2-yl) ethan-1-one (1 eq.) Was slowly added dropwise. The mixture was stirred at room temperature for 2 hours and heated at 100 占 폚 for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1 N HCl, aqueous NaHCO 3 solution and H 2 O. The extract was separated and purified by column chromatography to obtain 12-1.
화합물 12-2의 제조Preparation of Compound 12-2
화합물 5-1 대신 화합물 12-1을 사용한 것을 제외하고는, 제조예 5에서의 5-2의 제조와 동일한 방법으로 제조하여 화합물 12-2를 얻었다. Compound 12-2 was obtained in the same manner as in the production of 5-2 in Production Example 5 except that Compound 12-1 was used instead of Compound 5-1.
화합물 12-3의 제조Preparation of Compound 12-3
화합물 5-2 대신 화합물 12-2를 사용한 것을 제외하고는, 제조예 5에서의 5-3의 제조와 동일한 방법으로 제조하여 화합물 12-3을 얻었다. Compound 12-3 was obtained in the same manner as in the production of 5-3 in Production Example 5, except that Compound 12-2 was used instead of Compound 5-2.
화합물 12-4의 제조Preparation of Compound 12-4
화합물 5-3 대신 화합물 12-3을 사용한 것을 제외하고는, 제조예 5에서의 5-4의 제조와 동일한 방법으로 제조하여 화합물 12-4를 얻었다. Compound 12-4 was obtained in the same manner as in the production of 5-4 in Production Example 5 except that Compound 12-3 was used instead of Compound 5-3.
화합물 12-5의 제조Preparation of Compound 12-5
화합물 5-4 대신 화합물 12-4을 사용한 것을 제외하고는, 제조예 5에서의 5-5의 제조와 동일한 방법으로 제조하여 화합물 12-5를 얻었다. Compound 12-5 was obtained in the same manner as in the production of 5-5 in Production Example 5, except that Compound 12-4 was used instead of Compound 5-4.
화합물 compound P12P12 의 제조Manufacturing
화합물 5-5 대신 화합물 12-5를 사용한 것을 제외하고는, 제조예 5에서의 P5의 제조와 동일한 방법으로 제조하여 화합물 P12을 얻었다.Compound P12 was obtained in the same manner as in the production of P5 in Production Example 5, except that Compound 12-5 was used instead of Compound 5-5.
상기 제조예 12에서, S-1의 Ar을 하기 표 12과 같이 적용하여 화합물 99 및 100을 제조하였다.In Production Example 12, Ar of S-1 was applied as shown in the following Table 12 to produce
[제조예 13] 하기 표 13의 치환기를 갖는 화합물의 제조[Preparation Example 13] Preparation of a compound having a substituent shown in the following Table 13
화합물 13-1의 제조Preparation of Compound 13-1
메틸-2-브로모벤조에이트(methyl-2-bromobenzoate) (1 eq.)을 THF 180 mL에 녹인 후, NaH (2 eq.)을 넣고 30분 교반하였다. 교반 후, 1-(5-브로모나프탈렌-2-일)에탄-1-온(1-(5-bromonaphthalen-2-yl)ethan-1-one) (1 eq.)을 천천히 적가하였다. 상온에서 2시간 교반하고, 100℃에서 16시간 가열하였다. 반응이 완결되면 실온으로 온도를 내린 후, 에틸아세테이트(ethyl acetate) 와 1N HCl, NaHCO3 수용액, H2O을 이용하여 차례로 추출하였다. 추출 후 컬럼크로마토크래피로 분리 정제하여 13-1를 얻었다. Methyl-2-bromobenzoate (1 eq.) Was dissolved in 180 mL of THF, followed by addition of NaH (2 eq.) And stirring for 30 minutes. After stirring, 1- (5-bromonaphthalen-2-yl) ethan-1-one (1 eq.) Was slowly added dropwise. The mixture was stirred at room temperature for 2 hours and heated at 100 占 폚 for 16 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and extracted successively with ethyl acetate, 1N HCl, aqueous NaHCO 3 solution, and H 2 O. The extract was separated and purified by column chromatography to obtain 13-1.
화합물 13-2의 제조Preparation of Compound 13-2
화합물 5-1 대신 화합물 13-1을 사용한 것을 제외하고는, 제조예 5에서의 5-2의 제조와 동일한 방법으로 제조하여 화합물 13-2를 얻었다. Compound 13-2 was obtained in the same manner as in the production of 5-2 in Production Example 5 except that Compound 13-1 was used instead of Compound 5-1.
화합물 13-3의 제조Preparation of Compound 13-3
화합물 5-2 대신 화합물 13-2를 사용한 것을 제외하고는, 제조예 5에서의 5-3의 제조와 동일한 방법으로 제조하여 화합물 13-3을 얻었다. Compound 13-2 was prepared in the same manner as in the production of 5-3 in Production Example 5, except that Compound 13-2 was used instead of Compound 5-2.
화합물 13-4의 제조Preparation of Compound 13-4
화합물 5-3 대신 화합물 13-3을 사용한 것을 제외하고는, 제조예 5에서의 5-4의 제조와 동일한 방법으로 제조하여 화합물 13-4를 얻었다. Compound 13-4 was obtained in the same manner as in the production of 5-4 in Production Example 5 except that Compound 13-3 was used instead of Compound 5-3.
화합물 13-5의 제조Preparation of Compound 13-5
화합물 5-4 대신 화합물 13-4을 사용한 것을 제외하고는, 제조예 5에서의 5-5의 제조와 동일한 방법으로 제조하여 화합물 13-5를 얻었다. Compound 13-5 was obtained in the same manner as in the production of 5-5 in Production Example 5 except that Compound 13-4 was used instead of Compound 5-4.
화합물 compound P13P13 의 제조Manufacturing
화합물 5-5 대신 화합물 13-5를 사용한 것을 제외하고는, 제조예 5에서의 P5의 제조와 동일한 방법으로 제조하여 화합물 P13을 얻었다.Compound P13 was obtained in the same manner as in the production of P5 in Production Example 5, except that Compound 13-5 was used instead of Compound 5-5.
상기 제조예 13에서, S-1의 Ar을 하기 표 13과 같이 적용하여 화합물 96 내지 98을 제조하였다.In Preparation Example 13, Ar of S-1 was applied as shown in the following Table 13 to prepare Compounds 96 to 98.
상기 제조예들과 같은 방법으로 화합물을 제조하고, 그 합성확인결과를 하기 표 14에 나타내었다.The compounds were prepared in the same manner as in the above Preparation Examples, and the results of confirmation of the synthesis are shown in Table 14 below.
[실시예 1] 유기 발광 소자의 제작[Example 1] Production of organic light emitting device
하기의 같은 방법으로 유기 전계 발광 소자를 제조하였다. An organic electroluminescent device was prepared in the following manner.
ITO 두께가 1500 Å인 기판을 증류수에 담그고 초음파세척기를 이용하여 세척하였다. 증류수 세척이 끝나면 아세톤, 메탄올, 이소프로필 알코올 등의 용제로 초음파 세척을 하고 수분제거를 위해 건조시킨 후 UV 세정기에서 5분간 UVO 처리하였다. 이후 기판을 플라즈마 세정기(PT; Plasma Treatment)로 이송시킨 후, 유기소자의 정공(Hole) 주입특성의 향상 및 잔여막 제거를 위해 플라즈마 처리를 하여, 유기증착용 열증착 장비로 이송하였다.The substrate with ITO thickness of 1500 Å was immersed in distilled water and washed with an ultrasonic cleaner. After the distilled water was washed, it was ultrasonically washed with a solvent such as acetone, methanol, isopropyl alcohol, dried to remove water, and treated with UVO for 5 minutes in a UV scrubber. Subsequently, the substrate was transferred to a plasma cleaner (PT), plasma treatment was performed to improve the hole injection characteristics of the organic device and to remove the residual film, and the substrate was transferred to a thermal vapor deposition apparatus for vapor deposition.
상기 과정을 통해 처리되어진 ITO 투명 전극(양극)위에 N,N'-비스(a-나프틸)-N,N'-디페닐-4,4'-디아민(N,N'-bis(a-naphthyl)-N,N'-diphenyl-4,4'-diamine: NPB)을 400 Å의 두께로 열 진공 증착하여 정공 수송층을 형성하였다.N, N'-bis (a-naphthyl) -N, N'-diphenyl-4,4'-diamine (N, N'- naphthyl) -N, N'-diphenyl-4,4'-diamine: NPB) was deposited in a thickness of 400 Å by thermal vacuum deposition to form a hole transport layer.
NPBNPB
정공수송층을 형성시킨 후, 그 위에 발광층을 다음과 같이 열 진공 증착시켰다. 발광층은 호스트로 CBP(4,4'N,N' -dicarbazole-biphenyl), 녹색 인광도펀트로 Ir(ppy)3(tris(2-phenylpyridine)iridium)을 사용하여 CBP에 Ir(ppy)3를 7% 도핑하여 200Å 증착하였다. 이후 정공저지층으로 BCP를 100Å 증착하였으며, 그 위에 전자수송층으로 제조예 1~13에서 합성된 화합물 중 화합물 1~4, 6, 16, 19~21, 26, 49, 52, 71, 74, 76 및 101를 200Å 증착하였다. 마지막으로 전자 수송층 위에 리튬 플루오라이드(lithium fluoride)를 10Å 두께로 증착하여 전자 주입층을 형성한 후, 전자 주입층 위에 알루미늄(Al) 음극을 1200Å의 두께로 증착하여 음극을 형성함으로써 유기 전계 발광 소자를 제조하였다.After forming a hole transporting layer, a light emitting layer was formed thereon by thermal vacuum deposition as follows. The light-emitting layer CBP (4,4'N, N '-dicarbazole- biphenyl), a green phosphorescent dopant Ir (ppy) 3 (tris ( 2-phenylpyridine) iridium) of the Ir (ppy) 3 in CBP 7 with the host % ≪ / RTI > Then, BCP was deposited to a thickness of 100 Å as a hole blocking layer. As an electron transport layer, compounds 1 to 4, 6, 16, 19 to 21, 26, 49, 52, 71, 74 and 76 And 101 were deposited in a thickness of 200Å. Finally, lithium fluoride was deposited on the electron transport layer to a thickness of 10 Å to form an electron injection layer. An aluminum (Al) cathode was deposited on the electron injection layer to a thickness of 1200 Å to form a cathode. .
CBPCBP IrIr (( ppyppy )) 33 BCPBCP
[비교예 1] 유기 발광 소자의 제작[Comparative Example 1] Fabrication of an organic light emitting device
실시예 1에서 전자수송층 형성시 사용된 제조예 1~13에서 합성된 화합물 중 화합물 1~4, 6, 16, 19~21, 26, 49, 52, 71, 74, 76 및 101 대신 Alq3을 이용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 유기 전계 발광 소자를 제작하였다.Alq 3 was used instead of the compounds 1 to 4, 6, 16, 19 to 21, 26, 49, 52, 71, 74, 76 and 101 in the compounds synthesized in Production Examples 1 to 13 used in forming the electron transport layer in Example 1 , An organic electroluminescent device was fabricated in the same manner as in Example 1.
AlqAlq 33
[실험예 1] 유기 전계 발광 소자의 구동 전압 및 발광 효율[Experimental Example 1] Driving voltage and luminous efficiency of an organic electroluminescent device
상기와 같이 제조된 실시예 1 및 비교예 1에서 각각 제작된 유기 전계 발광 소자에 대하여 맥사이어스사의 M7000으로 전계발광(EL)특성을 측정하였으며, 그 측정 결과를 가지고 맥사이언스사에서 제조된 수명측정장비(M6000)를 통해 기준 휘도가 6000 cd/m2 일 때, T90을 측정하였다. 본 발명의 실시예 1과 비교예 1에 따라 제조된 유기전계발광소자의 구동전압, 휘도, 발광효율 그리고 수명을 측정한 결과는 표 15와 같다.
The electroluminescence (EL) characteristics of the organic electroluminescent device fabricated in the above-described Example 1 and Comparative Example 1 were measured by M7000 of Mitsubishi Electric Corporation, and the results of the measurement were used to determine the lifetime The T 90 was measured with a reference luminance of 6000 cd / m 2 through the equipment (M6000). Table 15 shows the results of measuring the driving voltage, the luminance, the luminous efficiency, and the lifetime of the organic EL device manufactured according to Example 1 and Comparative Example 1 of the present invention.
(V)Driving voltage
(V)
(cd/m2)Luminance
(cd / m 2 )
(cd/A)Luminous efficiency
(cd / A)
(x, y)CIE
(x, y)
(T90)life span
(T 90 )
상기 표 15에 나타난 바와 같이, 유기전계발광소자의 전자수송층 재료로서 본 출원의 화합물을 사용하는 경우 종래의 Alq3를 사용하는 경우보다 구동 전압이 낮고, 발광효율이 향상되었을 뿐만 아니라 수명도 현저히 개선된 것을 알 수 있다.As shown in Table 15, when the compound of the present application is used as the electron transport layer material of the organic electroluminescent device, the driving voltage is lower than that of the conventional Alq 3 , the luminous efficiency is improved, and the lifetime is significantly improved .
100 기판
200 양극
300 유기물층
301 정공주입층
302 정공수송층
303 발광층
304 정공저지층
305 전자수송층
306 전자주입층
400 음극100 substrate
200 anode
300 organic layer
301 hole injection layer
302 hole transport layer
303 luminous layer
304 hole stop layer
305 electron transport layer
306 electron injection layer
400 cathode
Claims (17)
[화학식 1]
상기 화학식 1에 있어서,
L1 내지 L3는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴렌; 또는 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴렌이고,
t는 0 내지 5의 정수이며,
R1 내지 R4는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐; 치환 또는 비치환된 C1 내지 C60의 직쇄 또는 분지쇄의 알킬; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알케닐; 치환 또는 비치환된 C2 내지 C60의 직쇄 또는 분지쇄의 알키닐; 치환 또는 비치환된 C3 내지 C60의 단환 또는 다환의 시클로알킬; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로시클로알킬; 치환 또는 비치환된 C6 내지 C60의 단환 또는 다환의 아릴; 치환 또는 비치환된 C2 내지 C60의 단환 또는 다환의 헤테로아릴; -SiRR'R"; -P(=O)RR' 및 -NRR'으로 이루어진 군으로부터 선택되며,
상기 R, R' 및 R"은 서로 동일하거나 상이하고, 각각 독립적으로 수소; C1 내지 C60의 직쇄 또는 분지쇄의 알킬; 치환 또는 비치환된 C3 내지 C60의 단환 또는 다환의 시클로알킬; C6 내지 C60의 단환 또는 다환의 아릴; 및 C2 내지 C60의 단환 또는 다환의 헤테로아릴로 이루어진 군으로부터 선택되며,
m 및 n은 각각 독립적으로 0 내지 4의 정수이고,
p 및 q는 각각 독립적으로 0 내지 2의 정수이며,
상기 m, n, p, q 및 t가 각각 2 이상의 정수일 때, 각각의 괄호 안에 있는 치환기는 서로 동일하거나 상이하다.A compound of formula
[Chemical Formula 1]
In Formula 1,
L1 to L3 are the same or different and each independently represents a substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic arylene; Or a substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroarylene,
t is an integer from 0 to 5,
R1 to R4 are the same or different from each other, and each independently hydrogen; heavy hydrogen; halogen; Substituted or unsubstituted C 1 to C 60 straight or branched alkyl; Substituted or unsubstituted C 2 to C 60 straight or branched chain alkenyl; Substituted or unsubstituted C 2 to C 60 straight or branched chain alkynyl; A substituted or unsubstituted C 3 to C 60 monocyclic or polycyclic cycloalkyl; Substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heterocycloalkyl; A substituted or unsubstituted C 6 to C 60 monocyclic or polycyclic aryl; Substituted or unsubstituted C 2 to C 60 monocyclic or polycyclic heteroaryl; -SiRR'R "; -P (= O) RR 'and -NRR'
Wherein R, R 'and R "are the same or different from each other and each independently represents hydrogen, C 1 to C 60 linear or branched alkyl, substituted or unsubstituted C 3 to C 60 monocyclic or polycyclic cycloalkyl C 6 to C 60 monocyclic or polycyclic aryl, and C 2 to C 60 monocyclic or polycyclic heteroaryl,
m and n are each independently an integer of 0 to 4,
p and q are each independently an integer of 0 to 2,
When m, n, p, q, and t are each an integer of 2 or more, the substituents in each parenthesis are the same or different from each other.
[화학식 2]
[화학식 3]
[화학식 4]
상기 화학식 2 내지 4에 있어서,
L1, L2, L3, t, R1, R2, R3, R4, m, n는 화학식 1에서 정의한 바와 동일하고,
R5 및 R6는 화학식 1의 R1의 정의와 동일하다.The compound according to claim 1, wherein the formula (1) is represented by any one of the following formulas (2) to (4)
(2)
(3)
[Chemical Formula 4]
In the above formulas 2 to 4,
R 1, R 2, R 3, R 4, m and n are the same as defined in formula (1)
R5 and R6 are the same as defined in R1 of formula (1).
C1~C20의 알킬, C6~C20의 아릴, 또는 C2~C20의 헤테로아릴로 더 치환되거나 비치환되는 것인 화합물.The compound according to claim 1, wherein L1 and L3 are the same or different from each other and each independently selected from the group consisting of phenylene, biphenylene, naphthylene, anthracenylene, pyridylene, pyrimidylene, and triazienylene,
A C 1 ~ C 20 alkyl, C 6 ~ C 20 aryl, or C 2 ~ C 20 heteroaryl further substituted by one or being unsubstituted compound.
C1~C20의 알킬, C6~C20의 아릴, 또는 C2~C20의 헤테로아릴로 더 치환되거나 비치환되는 것인 화합물.The compound according to claim 1, wherein L 2 is selected from the group consisting of phenylene, biphenylene, naphthylene, anthracenylene, phenanthrene, klychenylene, pyrenylene, triphenylenylene, pyridylene, pyrimidylene, But are not limited to, fluorene, spirocyclopentane fluorene, dibenzothiophenylene, dibenzoselenophenylene, dibenzosylolylene, acridinylene, xanthenylene, thioxanthrenylene , Dibenzosilinylene, and selenoxanthrenylene,
A C 1 ~ C 20 alkyl, C 6 ~ C 20 aryl, or C 2 ~ C 20 heteroaryl further substituted by one or being unsubstituted compound.
2. The compound according to claim 1, wherein said formula (1) is selected from the following formulas:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140080245A KR20160001537A (en) | 2014-06-27 | 2014-06-27 | Pyrazole-based compound and organic light emitting device using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140080245A KR20160001537A (en) | 2014-06-27 | 2014-06-27 | Pyrazole-based compound and organic light emitting device using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160001537A true KR20160001537A (en) | 2016-01-06 |
Family
ID=55165394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140080245A Withdrawn KR20160001537A (en) | 2014-06-27 | 2014-06-27 | Pyrazole-based compound and organic light emitting device using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160001537A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11760764B2 (en) | 2020-05-22 | 2023-09-19 | Aligos Therapeutics, Inc. | Methods and compositions for targeting PD-L1 |
-
2014
- 2014-06-27 KR KR1020140080245A patent/KR20160001537A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11760764B2 (en) | 2020-05-22 | 2023-09-19 | Aligos Therapeutics, Inc. | Methods and compositions for targeting PD-L1 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101838689B1 (en) | Hetero-cyclic compound and organic light emitting device using the same | |
KR102295197B1 (en) | Compound and organic light emitting device using the same | |
KR101571498B1 (en) | Polycyclic compound and organic light emitting device using the same | |
KR20150074603A (en) | Fluorene-based compound and organic light emitting device using the same | |
JP6615198B2 (en) | Nitrogen-containing polycyclic compound and organic light-emitting device using the same | |
KR102004231B1 (en) | Polycyclic compound including pyrazole and organic light emitting device using the same | |
KR101837029B1 (en) | Multicyclic compound and organic light emitting device using the same | |
CN112204022A (en) | Heterocyclic compound, organic light-emitting element including the same, composition of organic material layer for organic light-emitting element, and method for manufacturing organic light-emitting element | |
KR20160124623A (en) | Multicyclic compound including nitrogen and organic light emitting device using the same | |
KR20150027660A (en) | Fused cyclic compound including nitrogen and organic light emitting device using the same | |
KR101464133B1 (en) | Pyrazole-based compound and organic light emitting device using the same | |
JP6211189B2 (en) | Nitrogen-containing polycyclic compound and organic light-emitting device using the same | |
KR20190033911A (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR101616501B1 (en) | Multicyclic compound including nitrogen and organic light emitting device using the same | |
KR102473733B1 (en) | Multicyclic compound including nitrogen and organic light emitting device using the same | |
KR20160001537A (en) | Pyrazole-based compound and organic light emitting device using the same | |
KR20150074793A (en) | Pyrazole-based compound and organic light emitting device using the same | |
KR101597334B1 (en) | Fused hetero cyclic compound and organic light emitting device using the same | |
KR20140140455A (en) | Benzodiimidazole-based compound and organic light emitting device using the same | |
KR20160049800A (en) | Multicyclic compound including nitrogen and organic light emitting device using the same | |
KR102180745B1 (en) | Multicyclic compound including nitrogen and organic light emitting device using the same | |
KR20160008819A (en) | Hetero-cyclic compound and organic light emitting device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20140627 |
|
PG1501 | Laying open of application | ||
PC1203 | Withdrawal of no request for examination | ||
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |